|
OMIM |
Link |
Information gain |
01 |
|
SLEB3
|
[NCBI]
|
0.00223193
|
|
|
graves disease, susceptibility to, 2
|
[NCBI]
|
0.00176385
|
|
|
IBD2
|
[NCBI]
|
0.00165048
|
|
|
UFS
|
[NCBI]
|
0.00152247
|
|
|
IS1
|
[NCBI]
|
0.00125737
|
|
|
CRC
|
[NCBI]
|
0.00123728
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.00121344
|
|
|
NNCI
|
[NCBI]
|
0.00111508
|
|
|
myopia 14
|
[NCBI]
|
0.00111508
|
|
|
systemic lupus erythematosus, susceptibility to, 8
|
[NCBI]
|
0.00111508
|
|
|
melanoma, uveal, susceptibility to, 2
|
[NCBI]
|
0.00111508
|
|
|
RCM2
|
[NCBI]
|
0.00111508
|
|
|
porokeratosis, disseminated superficial actinic, 2
|
[NCBI]
|
0.00111508
|
|
|
diabetes mellitus, noninsulin-dependent, 4
|
[NCBI]
|
0.00111508
|
|
|
GLC1C
|
[NCBI]
|
0.00105074
|
|
|
hereditary motor and sensory neuropathy, type iic
|
[NCBI]
|
0.00105074
|
|
|
RA
|
[NCBI]
|
0.00100042
|
|
|
CF
|
[NCBI]
|
0.000991788
|
|
|
SLE
|
[NCBI]
|
0.000959432
|
|
|
systemic lupus erythematosus, susceptibility to, 6
|
[NCBI]
|
0.000909491
|
|
|
CNC2
|
[NCBI]
|
0.000909491
|
|
|
PSORS2
|
[NCBI]
|
0.000855435
|
|
|
AUTS4
|
[NCBI]
|
0.000801219
|
|
|
duane retraction syndrome 2
|
[NCBI]
|
0.000801219
|
|
|
MCKD1
|
[NCBI]
|
0.000792199
|
|
|
MTS
|
[NCBI]
|
0.000782201
|
|
|
cataract, central saccular, with sutural opacities
|
[NCBI]
|
0.0007604
|
|
|
systemic lupus erythematosus, susceptibility to, 7
|
[NCBI]
|
0.0007604
|
|
|
graves disease, susceptibility to, x-linked
|
[NCBI]
|
0.0007604
|
|
|
IDDM13
|
[NCBI]
|
0.0007604
|
|
|
stature quantitative trait locus 5
|
[NCBI]
|
0.0007604
|
|
|
amyotrophic lateral sclerosis 6
|
[NCBI]
|
0.0007604
|
|
|
IDDM15
|
[NCBI]
|
0.0007604
|
|
|
IBD9
|
[NCBI]
|
0.0007604
|
|
|
alzheimer disease 5
|
[NCBI]
|
0.000713863
|
|
|
DURS1
|
[NCBI]
|
0.000684358
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
0.00067759
|
|
|
diabetes mellitus, transient neonatal, 1
|
[NCBI]
|
0.00067759
|
|
|
lynch syndrome i
|
[NCBI]
|
0.000625701
|
|
|
cholesterol level quantitative trait locus 1
|
[NCBI]
|
0.000605934
|
|
|
ALSFTD1
|
[NCBI]
|
0.000605934
|
|
|
autoimmune thyroid disease, susceptibility to, 1
|
[NCBI]
|
0.000605934
|
|
|
asthma-related traits, susceptibility to, 3
|
[NCBI]
|
0.000605934
|
|
|
nonpapillary renal carcinoma 1
|
[NCBI]
|
0.000605934
|
|
|
parkinson disease 12
|
[NCBI]
|
0.000605934
|
|
|
CORD8
|
[NCBI]
|
0.000605934
|
|
|
DSMA3
|
[NCBI]
|
0.000605934
|
|
|
HPCX
|
[NCBI]
|
0.000578981
|
|
|
restless legs syndrome, susceptibility to, 4
|
[NCBI]
|
0.000557317
|
|
|
SQTL1
|
[NCBI]
|
0.000557317
|
|
|
melanoma, uveal, susceptibility to, 1
|
[NCBI]
|
0.000557317
|
|
|
DFNA30
|
[NCBI]
|
0.000557317
|
|
|
cataract, crystalline coralliform
|
[NCBI]
|
0.000557317
|
|
|
RP32
|
[NCBI]
|
0.000557317
|
|
|
RP22
|
[NCBI]
|
0.000557317
|
|
|
MRX72
|
[NCBI]
|
0.000557317
|
|
|
hypotrichosis simplex
|
[NCBI]
|
0.000557317
|
|
|
DFNB66
|
[NCBI]
|
0.000557317
|
|
|
wegener granulomatosis
|
[NCBI]
|
0.000557317
|
|
|
abidi x-linked mental retardation syndrome
|
[NCBI]
|
0.000557317
|
|
|
panic disorder 2
|
[NCBI]
|
0.000557317
|
|
|
RP28
|
[NCBI]
|
0.000557317
|
|
|
MRX52
|
[NCBI]
|
0.000557317
|
|
|
GLC1K
|
[NCBI]
|
0.000557317
|
|
|
MRT4
|
[NCBI]
|
0.000557317
|
|
|
RP33
|
[NCBI]
|
0.000557317
|
|
|
myoclonic epilepsy, infantile
|
[NCBI]
|
0.000557317
|
|
|
BMND6
|
[NCBI]
|
0.000557317
|
|
|
aortic aneurysm, familial abdominal 1
|
[NCBI]
|
0.000557317
|
|
|
AMCX5
|
[NCBI]
|
0.000557317
|
|
|
GLC1B
|
[NCBI]
|
0.000557317
|
|
|
GLC1F
|
[NCBI]
|
0.000557317
|
|
|
IBD8
|
[NCBI]
|
0.000557317
|
|
|
azoospermia, nonobstructive
|
[NCBI]
|
0.000557317
|
|
|
SPG24
|
[NCBI]
|
0.000557317
|
|
|
alzheimer disease 12
|
[NCBI]
|
0.000557317
|
|
|
DFNA47
|
[NCBI]
|
0.000557317
|
|
|
WM2
|
[NCBI]
|
0.000557317
|
|
|
CILD2
|
[NCBI]
|
0.000557317
|
|
|
SPAX2
|
[NCBI]
|
0.000557317
|
|
|
DFNA43
|
[NCBI]
|
0.000557317
|
|
|
SQTL2
|
[NCBI]
|
0.000557317
|
|
|
MRX73
|
[NCBI]
|
0.000557317
|
|
|
LAH3
|
[NCBI]
|
0.000557317
|
|
|
spinal muscular atrophy, distal, x-linked recessive
|
[NCBI]
|
0.000557317
|
|
|
preauricular tag, isolated, autosomal dominant, 1
|
[NCBI]
|
0.000557317
|
|
|
DFNM1
|
[NCBI]
|
0.000557317
|
|
|
MRX53
|
[NCBI]
|
0.000557317
|
|
|
migraine with aura, susceptibility to, 9
|
[NCBI]
|
0.000557317
|
|
|
autoimmune thyroid disease, susceptibility to, 4
|
[NCBI]
|
0.000557317
|
|
|
ovarian cancer, epithelial, susceptibility to
|
[NCBI]
|
0.000557317
|
|
|
major depressive disorder 1
|
[NCBI]
|
0.000557317
|
|
|
moyamoya disease 3
|
[NCBI]
|
0.000557317
|
|
|
OTSC2
|
[NCBI]
|
0.000557317
|
|
|
high density lipoprotein deficiency 3
|
[NCBI]
|
0.000557317
|
|
|
CATCN1
|
[NCBI]
|
0.000557317
|
|
|
acropectoral syndrome
|
[NCBI]
|
0.000557317
|
|
|
bone size quantitative trait locus 3
|
[NCBI]
|
0.000557317
|
|
|
RP23
|
[NCBI]
|
0.000557317
|
|
|
MCOPCB1
|
[NCBI]
|
0.000557317
|
|
|
STHAG5
|
[NCBI]
|
0.000557317
|
|
|
myopia 13
|
[NCBI]
|
0.000557317
|
|
|
anisomastia
|
[NCBI]
|
0.000557317
|
|
|
EJM4
|
[NCBI]
|
0.000557317
|
|
|
ATFB2
|
[NCBI]
|
0.000557317
|
|
|
SPOAN
|
[NCBI]
|
0.000557317
|
|
|
psoriasis susceptibility 7
|
[NCBI]
|
0.000557317
|
|
|
ETM3
|
[NCBI]
|
0.000557317
|
|
|
prostate cancer, hereditary, 7
|
[NCBI]
|
0.000557317
|
|
|
OTSC5
|
[NCBI]
|
0.000557317
|
|
|
PNKD2
|
[NCBI]
|
0.000557317
|
|
|
DFNB26
|
[NCBI]
|
0.000557317
|
|
|
dyskeratosis, hereditary benign intraepithelial
|
[NCBI]
|
0.000557317
|
|
|
SPG28
|
[NCBI]
|
0.000557317
|
|
|
SCKL3
|
[NCBI]
|
0.000557317
|
|
|
narcolepsy 2
|
[NCBI]
|
0.000557317
|
|
|
EIG2
|
[NCBI]
|
0.000557317
|
|
|
FEB6
|
[NCBI]
|
0.000557317
|
|
|
myopia 12
|
[NCBI]
|
0.000557317
|
|
|
GLC1J
|
[NCBI]
|
0.000557317
|
|
|
MYMY2
|
[NCBI]
|
0.000557317
|
|
|
peripheral arterial occlusive disease 1
|
[NCBI]
|
0.000557317
|
|
|
aortic aneurysm, familial abdominal 2
|
[NCBI]
|
0.000557317
|
|
|
armfield x-linked mental retardation syndrome
|
[NCBI]
|
0.000557317
|
|
|
HSCR8
|
[NCBI]
|
0.000557317
|
|
|
stature quantitative trait locus 4
|
[NCBI]
|
0.000557317
|
|
|
FGS4
|
[NCBI]
|
0.000557317
|
|
|
aneurysm, intracranial berry, 2
|
[NCBI]
|
0.000557317
|
|
|
DFNB68
|
[NCBI]
|
0.000557317
|
|
|
SPG29
|
[NCBI]
|
0.000557317
|
|
|
spondyloarthropathy, susceptibility to, 2
|
[NCBI]
|
0.000557317
|
|
|
cerebral palsy, ataxic, autosomal recessive
|
[NCBI]
|
0.000503234
|
|
|
SPG12
|
[NCBI]
|
0.000503234
|
|
|
plasmodium falciparum blood infection level
|
[NCBI]
|
0.000503234
|
|
|
migraine, familial typical, susceptibility to, 2
|
[NCBI]
|
0.000503234
|
|
|
AD14
|
[NCBI]
|
0.000503234
|
|
|
glomerulopathy with fibronectin deposits
|
[NCBI]
|
0.000503234
|
|
|
DYT7
|
[NCBI]
|
0.000503234
|
|
|
CORD7
|
[NCBI]
|
0.000503234
|
|
|
AD13
|
[NCBI]
|
0.000503234
|
|
|
stature as a quantitative trait
|
[NCBI]
|
0.000427022
|
|
|
CCA1
|
[NCBI]
|
0.000427022
|
|
|
CHED1
|
[NCBI]
|
0.000427022
|
|
|
HMN7A
|
[NCBI]
|
0.000427022
|
|
|
SRS
|
[NCBI]
|
0.000394336
|
|
|
AS
|
[NCBI]
|
0.000391789
|
|
|
hypotrichosis, marie unna type
|
[NCBI]
|
0.000367116
|
|
|
MEAX
|
[NCBI]
|
0.000367116
|
|
|
BMND3
|
[NCBI]
|
0.000367116
|
|
|
MYMY1
|
[NCBI]
|
0.000367116
|
|
|
thyroid carcinoma, nonmedullary, with or without cell oxyphilia
|
[NCBI]
|
0.000367116
|
|
|
schistosoma mansoni infection, susceptibility/resistance to
|
[NCBI]
|
0.000367116
|
|
|
IBD1
|
[NCBI]
|
0.000361655
|
|
|
MDD
|
[NCBI]
|
0.000343406
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.000318737
|
|
|
autism
|
[NCBI]
|
0.000309524
|
|
|
AITD3
|
[NCBI]
|
0.000305005
|
|
|
MRT12
|
[NCBI]
|
0.00030277
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 4
|
[NCBI]
|
0.00030277
|
|
|
myopia 5
|
[NCBI]
|
0.00030277
|
|
|
DFNA7
|
[NCBI]
|
0.00030277
|
|
|
DFNB13
|
[NCBI]
|
0.00030277
|
|
|
kala-azar, susceptibility to, 3
|
[NCBI]
|
0.00030277
|
|
|
malaria, mild, susceptibility to
|
[NCBI]
|
0.00030277
|
|
|
fasting glucose and specific insulin levels
|
[NCBI]
|
0.00030277
|
|
|
IBD4
|
[NCBI]
|
0.00030277
|
|
|
aortic aneurysm, familial thoracic 2
|
[NCBI]
|
0.00030277
|
|
|
psoriasis susceptibility 6
|
[NCBI]
|
0.00030277
|
|
|
myasthenia, familial infantile, 1
|
[NCBI]
|
0.00030277
|
|
|
AIS2
|
[NCBI]
|
0.00030277
|
|
|
migraine with or without aura, susceptibility to, 10
|
[NCBI]
|
0.00030277
|
|
|
GLC1I
|
[NCBI]
|
0.00030277
|
|
|
migraine with or without aura, susceptibility to, 11
|
[NCBI]
|
0.00030277
|
|
|
AIS3
|
[NCBI]
|
0.00030277
|
|
|
FSHMD1B
|
[NCBI]
|
0.00030277
|
|
|
LGMD1F
|
[NCBI]
|
0.00030277
|
|
|
intelligence quantitative trait locus 1
|
[NCBI]
|
0.00030277
|
|
|
ichthyosis prematurity syndrome
|
[NCBI]
|
0.00030277
|
|
|
kala-azar, susceptibility to, 2
|
[NCBI]
|
0.00030277
|
|
|
cone-rod dystrophy and amelogenesis imperfecta
|
[NCBI]
|
0.00030277
|
|
|
dermatoglyphics--fingerprint pattern
|
[NCBI]
|
0.00030277
|
|
|
acute insulin response
|
[NCBI]
|
0.00030277
|
|
|
ATOD5
|
[NCBI]
|
0.00030277
|
|
|
BMND5
|
[NCBI]
|
0.00030277
|
|
|
hyperaldosteronism, familial, type ii
|
[NCBI]
|
0.00030277
|
|
|
MCOPCB2
|
[NCBI]
|
0.00030277
|
|
|
prostate cancer, hereditary, 9
|
[NCBI]
|
0.00030277
|
|
|
CELIAC5
|
[NCBI]
|
0.00030277
|
|
|
MAFD4
|
[NCBI]
|
0.00030277
|
|
|
brachydactyly, type a1, b
|
[NCBI]
|
0.00030277
|
|
|
NEM6
|
[NCBI]
|
0.00030277
|
|
|
alzheimer disease 7
|
[NCBI]
|
0.00030277
|
|
|
cataract, autosomal recessive congenital 2
|
[NCBI]
|
0.00030277
|
|
|
MNG2
|
[NCBI]
|
0.00030277
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
0.0002782
|
|
|
SCZD6
|
[NCBI]
|
0.000277562
|
|
|
PWS
|
[NCBI]
|
0.00026212
|
|
|
MLH1
|
[NCBI]
|
0.000255433
|
|
|
PSORS1
|
[NCBI]
|
0.000249712
|
|
|
dermatitis, atopic
|
[NCBI]
|
0.000242939
|
|
|
AMCN
|
[NCBI]
|
0.000242939
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
0.000239197
|
|
|
AD
|
[NCBI]
|
0.00023825
|
|
|
MAFD1
|
[NCBI]
|
0.000236127
|
|
|
MSH6
|
[NCBI]
|
0.000230609
|
|
|
BHD
|
[NCBI]
|
0.000230249
|
|
|
PDB
|
[NCBI]
|
0.000222454
|
|
|
CHED2
|
[NCBI]
|
0.000218242
|
|
|
RMD1
|
[NCBI]
|
0.000213338
|
|
|
IDDM17
|
[NCBI]
|
0.000213338
|
|
|
persistent hyperplastic primary vitreous, autosomal recessive
|
[NCBI]
|
0.000213338
|
|
|
CFM1
|
[NCBI]
|
0.000213338
|
|
|
HSCR9
|
[NCBI]
|
0.000213338
|
|
|
DIH2
|
[NCBI]
|
0.000213338
|
|
|
diaphyseal medullary stenosis with malignant fibrous histiocytoma
|
[NCBI]
|
0.000213338
|
|
|
hypoadrenocorticism, familial
|
[NCBI]
|
0.000213338
|
|
|
van der woude syndrome modifier
|
[NCBI]
|
0.000213338
|
|
|
LI5
|
[NCBI]
|
0.000213338
|
|
|
cavitary optic disc anomalies
|
[NCBI]
|
0.000213338
|
|
|
cataract, autosomal recessive, early-onset, pulverulent
|
[NCBI]
|
0.000213338
|
|
|
asthma-related traits, susceptibility to, 6
|
[NCBI]
|
0.000213338
|
|
|
migraine without aura, susceptibility to, 4
|
[NCBI]
|
0.000213338
|
|
|
CSE
|
[NCBI]
|
0.000213338
|
|
|
myopia 6
|
[NCBI]
|
0.000213338
|
|
|
laterality defects, autosomal dominant
|
[NCBI]
|
0.000213338
|
|
|
leprosy, susceptibility to, 1
|
[NCBI]
|
0.000213338
|
|
|
vitreoretinal degeneration, snowflake type
|
[NCBI]
|
0.000213338
|
|
|
erythrokeratodermia variabilis 3
|
[NCBI]
|
0.000213338
|
|
|
IBD6
|
[NCBI]
|
0.000213338
|
|
|
prostate cancer, hereditary, 3
|
[NCBI]
|
0.000213338
|
|
|
DYT15
|
[NCBI]
|
0.000213338
|
|
|
PSORS3
|
[NCBI]
|
0.000213338
|
|
|
aortic aneurysm, familial thoracic 1
|
[NCBI]
|
0.000213338
|
|
|
wilms tumor 4
|
[NCBI]
|
0.000213338
|
|
|
IDDM11
|
[NCBI]
|
0.000213338
|
|
|
alzheimer disease 11
|
[NCBI]
|
0.000213338
|
|
|
macrocephaly with multiple epiphyseal dysplasia and distinctive facies
|
[NCBI]
|
0.000213338
|
|
|
SPG19
|
[NCBI]
|
0.000213338
|
|
|
vacuolar neuromyopathy
|
[NCBI]
|
0.000213338
|
|
|
OFC2
|
[NCBI]
|
0.000213338
|
|
|
PARK10
|
[NCBI]
|
0.000213338
|
|
|
ALSFTD2
|
[NCBI]
|
0.000213338
|
|
|
autoimmune thyroid disease, susceptibility to, 2
|
[NCBI]
|
0.000213338
|
|
|
restless legs syndrome, susceptibility to, 3
|
[NCBI]
|
0.000213338
|
|
|
branchiootic syndrome 2
|
[NCBI]
|
0.000213338
|
|
|
GLC1M
|
[NCBI]
|
0.000213338
|
|
|
patent ductus arteriosus
|
[NCBI]
|
0.000213338
|
|
|
SCAR6
|
[NCBI]
|
0.000213338
|
|
|
stature quantitative trait locus 2
|
[NCBI]
|
0.000213338
|
|
|
testicular microlithiasis
|
[NCBI]
|
0.000213338
|
|
|
epilepsy, myoclonic, benign adult familial, type 1
|
[NCBI]
|
0.000213132
|
|
|
OTSC1
|
[NCBI]
|
0.000213132
|
|
|
IBD5
|
[NCBI]
|
0.000213132
|
|
|
HPC1
|
[NCBI]
|
0.000207739
|
|
|
CJD
|
[NCBI]
|
0.000202716
|
|
|
EGF
|
[NCBI]
|
0.000201561
|
|
|
SCA6
|
[NCBI]
|
0.000194234
|
|
|
mismatch repair cancer syndrome
|
[NCBI]
|
0.000184486
|
|
|
CTPP3
|
[NCBI]
|
0.000179224
|
|
|
DFNA6
|
[NCBI]
|
0.000177656
|
|
|
ALUNC
|
[NCBI]
|
0.000177656
|
|
|
IDDM4
|
[NCBI]
|
0.000164492
|
|
|
spondyloocular syndrome, autosomal recessive
|
[NCBI]
|
0.000163962
|
|
|
CCA3
|
[NCBI]
|
0.000163962
|
|
|
SCZD9
|
[NCBI]
|
0.000163552
|
|
|
osteoarthritis
|
[NCBI]
|
0.000162087
|
|
|
SCZD
|
[NCBI]
|
0.000161213
|
|
|
HMPS1
|
[NCBI]
|
0.000159003
|
|
|
keratolytic winter erythema
|
[NCBI]
|
0.000159003
|
|
|
DYX5
|
[NCBI]
|
0.000159003
|
|
|
ALS5
|
[NCBI]
|
0.000159003
|
|
|
hypertension, essential, susceptibility to, 1
|
[NCBI]
|
0.000159003
|
|
|
DYX3
|
[NCBI]
|
0.000159003
|
|
|
MPD2
|
[NCBI]
|
0.000159003
|
|
|
dupuytren contracture
|
[NCBI]
|
0.000159003
|
|
|
ICCA
|
[NCBI]
|
0.000159003
|
|
|
stature quantitative trait locus 3
|
[NCBI]
|
0.000159003
|
|
|
cholestasis-lymphedema syndrome
|
[NCBI]
|
0.000159003
|
|
|
MYP3
|
[NCBI]
|
0.000159003
|
|
|
migraine with or without aura, susceptibility to, 6
|
[NCBI]
|
0.000159003
|
|
|
DYX6
|
[NCBI]
|
0.000159003
|
|
|
CTAA2
|
[NCBI]
|
0.000159003
|
|
|
peeling skin syndrome
|
[NCBI]
|
0.000159003
|
|
|
thyroid carcinoma, hurthle cell
|
[NCBI]
|
0.000159003
|
|
|
kala-azar, susceptibility to, 1
|
[NCBI]
|
0.000159003
|
|
|
sclerotylosis
|
[NCBI]
|
0.000159003
|
|
|
HHC3
|
[NCBI]
|
0.000159003
|
|
|
autism, susceptibility to, 3
|
[NCBI]
|
0.000159003
|
|
|
psoriasis susceptibility 8
|
[NCBI]
|
0.000159003
|
|
|
SCZD5
|
[NCBI]
|
0.000159003
|
|
|
nasopharyngeal carcinoma 1
|
[NCBI]
|
0.000159003
|
|
|
otitis media, susceptibility to
|
[NCBI]
|
0.000159003
|
|
|
NIDDM
|
[NCBI]
|
0.00015681
|
|
|
JPS
|
[NCBI]
|
0.000156381
|
|
|
HNSCC
|
[NCBI]
|
0.000151543
|
|
|
WT5
|
[NCBI]
|
0.000151543
|
|
|
VEGF
|
[NCBI]
|
0.000150683
|
|
|
MYP2
|
[NCBI]
|
0.000144461
|
|
|
MSH2
|
[NCBI]
|
0.000141796
|
|
|
OPLL
|
[NCBI]
|
0.00014162
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
0.000139006
|
|
|
SCA10
|
[NCBI]
|
0.000132871
|
|
|
VWS
|
[NCBI]
|
0.000130833
|
|
|
NGFB
|
[NCBI]
|
0.000127915
|
|
|
PAND1
|
[NCBI]
|
0.000126716
|
|
|
glaucoma-related pigment dispersion syndrome
|
[NCBI]
|
0.000126716
|
|
|
microduplication 22q11.2
|
[NCBI]
|
0.000126043
|
|
|
BOS3
|
[NCBI]
|
0.000126043
|
|
|
CNC1
|
[NCBI]
|
0.000125069
|
|
|
CMDR
|
[NCBI]
|
0.000121338
|
|
|
CTPP1
|
[NCBI]
|
0.000121338
|
|
|
CELIAC2
|
[NCBI]
|
0.000121338
|
|
|
syndactyly, type i
|
[NCBI]
|
0.000121338
|
|
|
CTAA1
|
[NCBI]
|
0.000121338
|
|
|
coronary heart disease, susceptibility to, 2
|
[NCBI]
|
0.000121338
|
|
|
convulsions, benign familial infantile, 1
|
[NCBI]
|
0.000121338
|
|
|
USH2B
|
[NCBI]
|
0.000121338
|
|
|
IBD3
|
[NCBI]
|
0.000121338
|
|
|
migraine with or without aura, susceptibility to, 5
|
[NCBI]
|
0.000121338
|
|
|
SCZD2
|
[NCBI]
|
0.000119531
|
|
|
prostate cancer
|
[NCBI]
|
0.000119467
|
|
|
PJS
|
[NCBI]
|
0.000119449
|
|
|
MAFD6
|
[NCBI]
|
0.000115121
|
|
|
melanoma-astrocytoma syndrome
|
[NCBI]
|
0.000109089
|
|
|
VAMAS1
|
[NCBI]
|
0.000109089
|
|
|
fanconi anemia, complementation group j
|
[NCBI]
|
0.000109089
|
|
|
AIS1
|
[NCBI]
|
0.000109089
|
|
|
LI3
|
[NCBI]
|
0.000109089
|
|
|
DPR
|
[NCBI]
|
0.000109089
|
|
|
ED2
|
[NCBI]
|
0.000108642
|
|
|
BBS
|
[NCBI]
|
0.000108201
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000107848
|
|
|
hypertension, essential
|
[NCBI]
|
0.000106358
|
|
|
MG
|
[NCBI]
|
0.000106026
|
|
|
MLH3
|
[NCBI]
|
0.000105458
|
|
|
PTH
|
[NCBI]
|
0.000103417
|
|
|
PALS
|
[NCBI]
|
9.96315e-05
|
|
|
MCPH1
|
[NCBI]
|
9.96315e-05
|
|
|
SCA7
|
[NCBI]
|
9.77743e-05
|
|
|
CCZS
|
[NCBI]
|
9.75565e-05
|
|
|
asthma-related traits, susceptibility to, 1
|
[NCBI]
|
9.75565e-05
|
|
|
MRX54
|
[NCBI]
|
9.75565e-05
|
|
|
LI2
|
[NCBI]
|
9.75565e-05
|
|
|
novelty seeking personality trait
|
[NCBI]
|
9.75565e-05
|
|
|
NPHP4
|
[NCBI]
|
9.75565e-05
|
|
|
gastric cancer
|
[NCBI]
|
9.58692e-05
|
|
|
PFM
|
[NCBI]
|
9.5657e-05
|
|
|
PRL
|
[NCBI]
|
9.50371e-05
|
|
|
trichoepithelioma, multiple familial
|
[NCBI]
|
9.34927e-05
|
|
|
SCAX1
|
[NCBI]
|
9.34927e-05
|
|
|
vestibulopathy, familial
|
[NCBI]
|
9.34927e-05
|
|
|
SCZD10
|
[NCBI]
|
9.34927e-05
|
|
|
MKS2
|
[NCBI]
|
9.34927e-05
|
|
|
RNANC
|
[NCBI]
|
9.34927e-05
|
|
|
panbronchiolitis, diffuse
|
[NCBI]
|
9.34927e-05
|
|
|
hereditary motor and sensory neuropathy v
|
[NCBI]
|
9.34927e-05
|
|
|
EKD2
|
[NCBI]
|
9.34927e-05
|
|
|
HPC10
|
[NCBI]
|
9.34927e-05
|
|
|
NIDDM2
|
[NCBI]
|
9.34927e-05
|
|
|
DYX2
|
[NCBI]
|
9.19722e-05
|
|
|
hydatidiform mole
|
[NCBI]
|
9.19722e-05
|
|
|
SPG4
|
[NCBI]
|
9.13636e-05
|
|
|
MRT1
|
[NCBI]
|
8.87975e-05
|
|
|
RP17
|
[NCBI]
|
8.87975e-05
|
|
|
RP13
|
[NCBI]
|
8.87975e-05
|
|
|
camurati-engelmann disease
|
[NCBI]
|
8.85404e-05
|
|
|
FHM2
|
[NCBI]
|
8.85404e-05
|
|
|
DHS
|
[NCBI]
|
8.43178e-05
|
|
|
CDAN2
|
[NCBI]
|
8.43178e-05
|
|
|
CACNA1A
|
[NCBI]
|
8.28342e-05
|
|
|
MSS
|
[NCBI]
|
8.2321e-05
|
|
|
mycobacterium tuberculosis, susceptibility to, x-linked
|
[NCBI]
|
8.1973e-05
|
|
|
angioma, tufted
|
[NCBI]
|
8.1973e-05
|
|
|
PFMCCD
|
[NCBI]
|
8.1973e-05
|
|
|
CATCN3
|
[NCBI]
|
8.1973e-05
|
|
|
USH2D
|
[NCBI]
|
8.1973e-05
|
|
|
hepatic adenomas, familial
|
[NCBI]
|
8.1973e-05
|
|
|
epilepsy, x-linked, with variable learning disabilities and behavior disorders
|
[NCBI]
|
8.1973e-05
|
|
|
cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome
|
[NCBI]
|
8.1973e-05
|
|
|
3-@methylglutaconic aciduria, type v
|
[NCBI]
|
8.1973e-05
|
|
|
cutis verticis gyrata, retinitis pigmentosa, and sensorineural deafness
|
[NCBI]
|
8.1973e-05
|
|
|
ROCA
|
[NCBI]
|
8.1973e-05
|
|
|
peters anomaly with cataract
|
[NCBI]
|
8.1973e-05
|
|
|
systemic lupus erythematosus, susceptibility to, 9
|
[NCBI]
|
8.1973e-05
|
|
|
craniosynostosis syndrome, autosomal recessive
|
[NCBI]
|
8.1973e-05
|
|
|
ATFB3
|
[NCBI]
|
8.1973e-05
|
|
|
CCA2
|
[NCBI]
|
8.1746e-05
|
|
|
naegeli syndrome
|
[NCBI]
|
8.1746e-05
|
|
|
IDDM5
|
[NCBI]
|
8.1746e-05
|
|
|
pierson syndrome
|
[NCBI]
|
8.1746e-05
|
|
|
CZP3
|
[NCBI]
|
8.1746e-05
|
|
|
TGFBR2
|
[NCBI]
|
7.83948e-05
|
|
|
prostate cancer/brain cancer susceptibility
|
[NCBI]
|
7.58566e-05
|
|
|
vitiligo
|
[NCBI]
|
7.58566e-05
|
|
|
AMDM
|
[NCBI]
|
7.58566e-05
|
|
|
PEE1
|
[NCBI]
|
7.40909e-05
|
|
|
SCZD3
|
[NCBI]
|
7.30918e-05
|
|
|
DM2
|
[NCBI]
|
7.29179e-05
|
|
|
APC
|
[NCBI]
|
7.26898e-05
|
|
|
AVP
|
[NCBI]
|
7.25119e-05
|
|
|
spiegler-brooke syndrome
|
[NCBI]
|
7.21355e-05
|
|
|
IH
|
[NCBI]
|
7.21355e-05
|
|
|
APS2
|
[NCBI]
|
7.21355e-05
|
|
|
DBQD
|
[NCBI]
|
7.21355e-05
|
|
|
neuropathy, hereditary motor and sensory, russe type
|
[NCBI]
|
7.21355e-05
|
|
|
CFEOM3
|
[NCBI]
|
7.21355e-05
|
|
|
SPG5A
|
[NCBI]
|
7.21355e-05
|
|
|
renal cell carcinoma, papillary, 3
|
[NCBI]
|
7.21355e-05
|
|
|
PSORS4
|
[NCBI]
|
7.21355e-05
|
|
|
MICA
|
[NCBI]
|
7.14617e-05
|
|
|
tobacco addiction, susceptibility to
|
[NCBI]
|
7.08111e-05
|
|
|
hyperlipidemia, combined, 1
|
[NCBI]
|
7.08111e-05
|
|
|
NPHP3
|
[NCBI]
|
7.08111e-05
|
|
|
SPG10
|
[NCBI]
|
7.08111e-05
|
|
|
CMT2D
|
[NCBI]
|
7.08111e-05
|
|
|
IL10
|
[NCBI]
|
7.06636e-05
|
|
|
IL6R
|
[NCBI]
|
7.03583e-05
|
|
|
CFNS
|
[NCBI]
|
6.96025e-05
|
|
|
MHA
|
[NCBI]
|
6.96025e-05
|
|
|
SHFM1
|
[NCBI]
|
6.84015e-05
|
|
|
DYX1
|
[NCBI]
|
6.74317e-05
|
|
|
SNCA
|
[NCBI]
|
6.65892e-05
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
6.64068e-05
|
|
|
spinocerebellar ataxia, 16q22-linked
|
[NCBI]
|
6.64068e-05
|
|
|
PKD3
|
[NCBI]
|
6.64068e-05
|
|
|
MCPH5
|
[NCBI]
|
6.64068e-05
|
|
|
BRIC1
|
[NCBI]
|
6.64068e-05
|
|
|
SPG17
|
[NCBI]
|
6.64068e-05
|
|
|
TCF7L2
|
[NCBI]
|
6.53008e-05
|
|
|
GFAP
|
[NCBI]
|
6.50078e-05
|
|
|
WFS1
|
[NCBI]
|
6.4337e-05
|
|
|
AMC
|
[NCBI]
|
6.42312e-05
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
6.33839e-05
|
|
|
EPO
|
[NCBI]
|
6.31473e-05
|
|
|
JBTS1
|
[NCBI]
|
6.30538e-05
|
|
|
PCOS1
|
[NCBI]
|
6.28497e-05
|
|
|
ATS
|
[NCBI]
|
6.25066e-05
|
|
|
RP11
|
[NCBI]
|
6.25066e-05
|
|
|
SPG6
|
[NCBI]
|
6.25066e-05
|
|
|
HNPCC2
|
[NCBI]
|
6.25066e-05
|
|
|
GINGF
|
[NCBI]
|
6.25066e-05
|
|
|
OCD1
|
[NCBI]
|
6.25066e-05
|
|
|
LRP5
|
[NCBI]
|
6.23157e-05
|
|
|
MYH9
|
[NCBI]
|
6.23157e-05
|
|
|
NOTCH4
|
[NCBI]
|
6.21674e-05
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
6.14924e-05
|
|
|
MEN1
|
[NCBI]
|
6.11448e-05
|
|
|
CCK
|
[NCBI]
|
6.10588e-05
|
|
|
MBD4
|
[NCBI]
|
5.99338e-05
|
|
|
MS
|
[NCBI]
|
5.9767e-05
|
|
|
graves disease
|
[NCBI]
|
5.96806e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
5.90132e-05
|
|
|
mitochondrial dna depletion syndrome, myopathic form
|
[NCBI]
|
5.90132e-05
|
|
|
congenital cataracts, facial dysmorphism, and neuropathy
|
[NCBI]
|
5.90132e-05
|
|
|
SNDI
|
[NCBI]
|
5.90132e-05
|
|
|
CYLD
|
[NCBI]
|
5.90132e-05
|
|
|
CMT2B
|
[NCBI]
|
5.90132e-05
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
5.74431e-05
|
|
|
behcet syndrome
|
[NCBI]
|
5.74431e-05
|
|
|
BDNF
|
[NCBI]
|
5.71792e-05
|
|
|
LEP
|
[NCBI]
|
5.71634e-05
|
|
|
ALD
|
[NCBI]
|
5.68122e-05
|
|
|
CRH
|
[NCBI]
|
5.63083e-05
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
5.62749e-05
|
|
|
FLCN
|
[NCBI]
|
5.61846e-05
|
|
|
ZNF9
|
[NCBI]
|
5.61846e-05
|
|
|
NPY
|
[NCBI]
|
5.58736e-05
|
|
|
ARH
|
[NCBI]
|
5.58552e-05
|
|
|
DSMA1
|
[NCBI]
|
5.58552e-05
|
|
|
THC2
|
[NCBI]
|
5.58552e-05
|
|
|
CMT2A1
|
[NCBI]
|
5.58552e-05
|
|
|
FTNS
|
[NCBI]
|
5.58552e-05
|
|
|
NCIE1
|
[NCBI]
|
5.58552e-05
|
|
|
neuroticism
|
[NCBI]
|
5.53905e-05
|
|
|
MCOPS1
|
[NCBI]
|
5.53905e-05
|
|
|
short rib-polydactyly syndrome, type iii
|
[NCBI]
|
5.53905e-05
|
|
|
gastroesophageal reflux
|
[NCBI]
|
5.53905e-05
|
|
|
myoclonic epilepsy, juvenile, 3
|
[NCBI]
|
5.53905e-05
|
|
|
FKTN
|
[NCBI]
|
5.4578e-05
|
|
|
WFS2
|
[NCBI]
|
5.45367e-05
|
|
|
mental retardation, x-linked, with short stature, small testes, muscle wasting, and tremor
|
[NCBI]
|
5.45367e-05
|
|
|
PPCD3
|
[NCBI]
|
5.45367e-05
|
|
|
peeling skin syndrome, acral type
|
[NCBI]
|
5.45367e-05
|
|
|
microphthalmia, isolated, with cataract 4
|
[NCBI]
|
5.45367e-05
|
|
|
LGMD2G
|
[NCBI]
|
5.45367e-05
|
|
|
SLSN4
|
[NCBI]
|
5.45367e-05
|
|
|
myelofibrosis, familial
|
[NCBI]
|
5.45367e-05
|
|
|
IS3
|
[NCBI]
|
5.45367e-05
|
|
|
HMPS2
|
[NCBI]
|
5.45367e-05
|
|
|
retinopathy, pigmentary, and mental retardation
|
[NCBI]
|
5.45367e-05
|
|
|
JBTS4
|
[NCBI]
|
5.45367e-05
|
|
|
CLSD
|
[NCBI]
|
5.45367e-05
|
|
|
pilomatrixoma
|
[NCBI]
|
5.45367e-05
|
|
|
cataract, lamellar 2
|
[NCBI]
|
5.45367e-05
|
|
|
williams-beuren region duplication syndrome
|
[NCBI]
|
5.45367e-05
|
|
|
dystonia, juvenile-onset
|
[NCBI]
|
5.45367e-05
|
|
|
radial aplasia, x-linked
|
[NCBI]
|
5.45367e-05
|
|
|
brevican
|
[NCBI]
|
5.45367e-05
|
|
|
diabetes mellitus, transient neonatal, 3
|
[NCBI]
|
5.45367e-05
|
|
|
heterotopia, periventricular, autosomal recessive
|
[NCBI]
|
5.45367e-05
|
|
|
MRX45
|
[NCBI]
|
5.45367e-05
|
|
|
malignant hyperthermia, susceptibility to, 5
|
[NCBI]
|
5.45367e-05
|
|
|
PPCD2
|
[NCBI]
|
5.45367e-05
|
|
|
LCCS2
|
[NCBI]
|
5.45367e-05
|
|
|
DFNA44
|
[NCBI]
|
5.45367e-05
|
|
|
urticaria, familial localized heat
|
[NCBI]
|
5.45367e-05
|
|
|
MRXS10
|
[NCBI]
|
5.45367e-05
|
|
|
bothnia retinal dystrophy
|
[NCBI]
|
5.45367e-05
|
|
|
heterotopia, periventricular, ehlers-danlos variant
|
[NCBI]
|
5.45367e-05
|
|
|
spondyloepimetaphyseal dysplasia, type ii
|
[NCBI]
|
5.45367e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2l
|
[NCBI]
|
5.45367e-05
|
|
|
KLK3
|
[NCBI]
|
5.3292e-05
|
|
|
MSX2
|
[NCBI]
|
5.31093e-05
|
|
|
ATXN2
|
[NCBI]
|
5.31093e-05
|
|
|
AGS1
|
[NCBI]
|
5.29783e-05
|
|
|
sitosterolemia
|
[NCBI]
|
5.29783e-05
|
|
|
PNDM
|
[NCBI]
|
5.29783e-05
|
|
|
SUCLA2
|
[NCBI]
|
5.27182e-05
|
|
|
FANCA
|
[NCBI]
|
5.23538e-05
|
|
|
MAFD2
|
[NCBI]
|
5.21898e-05
|
|
|
SHOX
|
[NCBI]
|
5.17459e-05
|
|
|
FCAS
|
[NCBI]
|
5.16432e-05
|
|
|
NOD2
|
[NCBI]
|
5.11545e-05
|
|
|
BCNS
|
[NCBI]
|
5.11388e-05
|
|
|
PCNA
|
[NCBI]
|
5.06615e-05
|
|
|
COCH
|
[NCBI]
|
5.05039e-05
|
|
|
FOXP2
|
[NCBI]
|
5.05039e-05
|
|
|
SVAS
|
[NCBI]
|
5.03837e-05
|
|
|
esophageal cancer
|
[NCBI]
|
5.03407e-05
|
|
|
muckle-wells syndrome
|
[NCBI]
|
5.03407e-05
|
|
|
GAN1
|
[NCBI]
|
5.03407e-05
|
|
|
SOST
|
[NCBI]
|
5.03407e-05
|
|
|
WFS1
|
[NCBI]
|
5.02113e-05
|
|
|
BMPR1A
|
[NCBI]
|
4.93369e-05
|
|
|
NF1
|
[NCBI]
|
4.89488e-05
|
|
|
CRYBA1
|
[NCBI]
|
4.82451e-05
|
|
|
CYP11A1
|
[NCBI]
|
4.82451e-05
|
|
|
robinow syndrome, autosomal recessive
|
[NCBI]
|
4.79092e-05
|
|
|
HSAN2
|
[NCBI]
|
4.79092e-05
|
|
|
NBIA1
|
[NCBI]
|
4.79092e-05
|
|
|
ALOXE3
|
[NCBI]
|
4.7611e-05
|
|
|
GLC1A
|
[NCBI]
|
4.74965e-05
|
|
|
HSCR1
|
[NCBI]
|
4.72929e-05
|
|
|
infantile spasm syndrome, x-linked
|
[NCBI]
|
4.56569e-05
|
|
|
SPCH1
|
[NCBI]
|
4.56569e-05
|
|
|
CACNA1S
|
[NCBI]
|
4.53385e-05
|
|
|
MPO
|
[NCBI]
|
4.49603e-05
|
|
|
MCPH6
|
[NCBI]
|
4.43911e-05
|
|
|
FECD1
|
[NCBI]
|
4.43911e-05
|
|
|
male infertility with large-headed, multiflagellar, polyploid spermatozoa
|
[NCBI]
|
4.43911e-05
|
|
|
carcinoid tumors, intestinal
|
[NCBI]
|
4.43911e-05
|
|
|
MRT3
|
[NCBI]
|
4.43911e-05
|
|
|
SCA11
|
[NCBI]
|
4.43911e-05
|
|
|
pierre robin syndrome
|
[NCBI]
|
4.43911e-05
|
|
|
spondyloepiphyseal dysplasia, kimberley type
|
[NCBI]
|
4.43911e-05
|
|
|
stroke, susceptibility to, 1
|
[NCBI]
|
4.43911e-05
|
|
|
LCA4
|
[NCBI]
|
4.43911e-05
|
|
|
dehydrated hereditary stomatocytosis, pseudohyperkalemia, and perinatal edema
|
[NCBI]
|
4.43911e-05
|
|
|
DFNB31
|
[NCBI]
|
4.43911e-05
|
|
|
otofaciocervical syndrome
|
[NCBI]
|
4.43911e-05
|
|
|
myocardial infarction, susceptibility to, 2
|
[NCBI]
|
4.43911e-05
|
|
|
SPS
|
[NCBI]
|
4.43911e-05
|
|
|
urticaria, aquagenic
|
[NCBI]
|
4.43911e-05
|
|
|
ATOD4
|
[NCBI]
|
4.43911e-05
|
|
|
MRX63
|
[NCBI]
|
4.43911e-05
|
|
|
diabetes mellitus, permanent neonatal, with cerebellar agenesis
|
[NCBI]
|
4.43911e-05
|
|
|
MRX58
|
[NCBI]
|
4.43911e-05
|
|
|
aortic aneurysm, familial thoracic 4
|
[NCBI]
|
4.43911e-05
|
|
|
siderius x-linked mental retardation syndrome
|
[NCBI]
|
4.43911e-05
|
|
|
HMERF
|
[NCBI]
|
4.43911e-05
|
|
|
autism, x-linked, susceptibility to, 1
|
[NCBI]
|
4.43911e-05
|
|
|
leprosy, susceptibility to, 4
|
[NCBI]
|
4.43911e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2e
|
[NCBI]
|
4.43911e-05
|
|
|
SLEB2
|
[NCBI]
|
4.43911e-05
|
|
|
DDU
|
[NCBI]
|
4.43911e-05
|
|
|
meniere disease
|
[NCBI]
|
4.43911e-05
|
|
|
ABCA12
|
[NCBI]
|
4.41135e-05
|
|
|
IGER
|
[NCBI]
|
4.3758e-05
|
|
|
HGF
|
[NCBI]
|
4.35789e-05
|
|
|
DCC
|
[NCBI]
|
4.26098e-05
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
4.21799e-05
|
|
|
kabuki syndrome
|
[NCBI]
|
4.21799e-05
|
|
|
CRYAA
|
[NCBI]
|
4.21122e-05
|
|
|
SCZD7
|
[NCBI]
|
4.20942e-05
|
|
|
hypertension with brachydactyly
|
[NCBI]
|
4.20942e-05
|
|
|
digeorge syndrome/velocardiofacial syndrome spectrum of malformation 2
|
[NCBI]
|
4.20942e-05
|
|
|
IGES
|
[NCBI]
|
4.20942e-05
|
|
|
spinocerebellar ataxia 29
|
[NCBI]
|
4.20942e-05
|
|
|
MYOC
|
[NCBI]
|
4.20255e-05
|
|
|
GEFS+
|
[NCBI]
|
4.16065e-05
|
|
|
JBS
|
[NCBI]
|
4.16065e-05
|
|
|
IBM2
|
[NCBI]
|
4.16065e-05
|
|
|
bethlem myopathy
|
[NCBI]
|
4.16065e-05
|
|
|
KCNQ1
|
[NCBI]
|
4.14707e-05
|
|
|
SLC11A1
|
[NCBI]
|
4.14707e-05
|
|
|
SLC2A10
|
[NCBI]
|
4.14397e-05
|
|
|
ALOX12B
|
[NCBI]
|
4.14397e-05
|
|
|
FBN1
|
[NCBI]
|
4.08095e-05
|
|
|
PMS2
|
[NCBI]
|
4.07072e-05
|
|
|
ATXN8OS
|
[NCBI]
|
4.00473e-05
|
|
|
PLOSL
|
[NCBI]
|
3.97753e-05
|
|
|
HEPOD
|
[NCBI]
|
3.97753e-05
|
|
|
ORW2
|
[NCBI]
|
3.97753e-05
|
|
|
AAA
|
[NCBI]
|
3.97753e-05
|
|
|
polycythemia vera
|
[NCBI]
|
3.97753e-05
|
|
|
OFC1
|
[NCBI]
|
3.97169e-05
|
|
|
CTNNA2
|
[NCBI]
|
3.92729e-05
|
|
|
WHRN
|
[NCBI]
|
3.92729e-05
|
|
|
HRPT2
|
[NCBI]
|
3.92729e-05
|
|
|
CHMP4B
|
[NCBI]
|
3.92729e-05
|
|
|
ARX
|
[NCBI]
|
3.88021e-05
|
|
|
NHS
|
[NCBI]
|
3.80556e-05
|
|
|
EDMD2
|
[NCBI]
|
3.80556e-05
|
|
|
APL
|
[NCBI]
|
3.80556e-05
|
|
|
asthma-related traits, susceptibility to, 2
|
[NCBI]
|
3.79209e-05
|
|
|
HAE III
|
[NCBI]
|
3.79209e-05
|
|
|
laurence-moon syndrome
|
[NCBI]
|
3.79209e-05
|
|
|
platelet disorder, familial, with associated myeloid malignancy
|
[NCBI]
|
3.79209e-05
|
|
|
PRTS
|
[NCBI]
|
3.79209e-05
|
|
|
LAH
|
[NCBI]
|
3.79209e-05
|
|
|
CORD6
|
[NCBI]
|
3.79209e-05
|
|
|
HHF4
|
[NCBI]
|
3.79209e-05
|
|
|
leprosy, susceptibility to, 2
|
[NCBI]
|
3.79209e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 2
|
[NCBI]
|
3.79209e-05
|
|
|
CFEOM2
|
[NCBI]
|
3.79209e-05
|
|
|
SPG8
|
[NCBI]
|
3.79209e-05
|
|
|
retinitis pigmentosa-deafness syndrome
|
[NCBI]
|
3.79209e-05
|
|
|
myxoma, intracardiac
|
[NCBI]
|
3.79209e-05
|
|
|
ependymoma, familial
|
[NCBI]
|
3.79209e-05
|
|
|
coronary heart disease, susceptibility to, 5
|
[NCBI]
|
3.79209e-05
|
|
|
HHF3
|
[NCBI]
|
3.79209e-05
|
|
|
CHBL
|
[NCBI]
|
3.79209e-05
|
|
|
USH1G
|
[NCBI]
|
3.79209e-05
|
|
|
rett syndrome, atypical, cdkl5-related
|
[NCBI]
|
3.79209e-05
|
|
|
lactase deficiency, congenital
|
[NCBI]
|
3.79209e-05
|
|
|
weill-marchesani syndrome, autosomal dominant
|
[NCBI]
|
3.79209e-05
|
|
|
bietti crystalline corneoretinal dystrophy
|
[NCBI]
|
3.79209e-05
|
|
|
LGMD2K
|
[NCBI]
|
3.79209e-05
|
|
|
MRT2
|
[NCBI]
|
3.79209e-05
|
|
|
PURE&apos
|
[NCBI]
|
3.79209e-05
|
|
|
SMS
|
[NCBI]
|
3.7878e-05
|
|
|
AVPR1A
|
[NCBI]
|
3.74512e-05
|
|
|
LAMB2
|
[NCBI]
|
3.74512e-05
|
|
|
TM4SF2
|
[NCBI]
|
3.74512e-05
|
|
|
IDDM
|
[NCBI]
|
3.70552e-05
|
|
|
PPH1
|
[NCBI]
|
3.64364e-05
|
|
|
GPR98
|
[NCBI]
|
3.58801e-05
|
|
|
MKKS
|
[NCBI]
|
3.58801e-05
|
|
|
FRZB
|
[NCBI]
|
3.58801e-05
|
|
|
MLC
|
[NCBI]
|
3.49084e-05
|
|
|
MORF4
|
[NCBI]
|
3.44995e-05
|
|
|
CDH13
|
[NCBI]
|
3.44995e-05
|
|
|
ANKH
|
[NCBI]
|
3.44995e-05
|
|
|
FCMD
|
[NCBI]
|
3.44506e-05
|
|
|
CAT
|
[NCBI]
|
3.38273e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
3.37494e-05
|
|
|
SCDO1
|
[NCBI]
|
3.34634e-05
|
|
|
KERA
|
[NCBI]
|
3.32685e-05
|
|
|
AAAS
|
[NCBI]
|
3.32685e-05
|
|
|
CACP
|
[NCBI]
|
3.31963e-05
|
|
|
JAE
|
[NCBI]
|
3.31963e-05
|
|
|
IDDM10
|
[NCBI]
|
3.31963e-05
|
|
|
IDDM12
|
[NCBI]
|
3.31963e-05
|
|
|
CSCD
|
[NCBI]
|
3.31963e-05
|
|
|
retinitis pigmentosa, x-linked, with recurrent respiratory infections
|
[NCBI]
|
3.31963e-05
|
|
|
RTADR
|
[NCBI]
|
3.31963e-05
|
|
|
KRS
|
[NCBI]
|
3.31963e-05
|
|
|
hydroxyacyl-coa dehydrogenase ii deficiency
|
[NCBI]
|
3.31963e-05
|
|
|
weyers acrofacial dysostosis
|
[NCBI]
|
3.31963e-05
|
|
|
pulmonary alveolar microlithiasis
|
[NCBI]
|
3.31963e-05
|
|
|
MRX59
|
[NCBI]
|
3.31963e-05
|
|
|
STL3
|
[NCBI]
|
3.31963e-05
|
|
|
POF2A
|
[NCBI]
|
3.31963e-05
|
|
|
monosomy 9p syndrome
|
[NCBI]
|
3.31963e-05
|
|
|
AH
|
[NCBI]
|
3.31963e-05
|
|
|
HCHOLA3
|
[NCBI]
|
3.31963e-05
|
|
|
dentin dysplasia, type ii
|
[NCBI]
|
3.31963e-05
|
|
|
cystinosis, late-onset juvenile or adolescent nephropathic type
|
[NCBI]
|
3.31963e-05
|
|
|
vasculopathy, retinal, with cerebral leukodystrophy
|
[NCBI]
|
3.31963e-05
|
|
|
SPS
|
[NCBI]
|
3.29019e-05
|
|
|
PTEN
|
[NCBI]
|
3.25184e-05
|
|
|
TNFRSF1A
|
[NCBI]
|
3.24033e-05
|
|
|
MSH3
|
[NCBI]
|
3.21583e-05
|
|
|
MLC1
|
[NCBI]
|
3.21583e-05
|
|
|
BRIP1
|
[NCBI]
|
3.21583e-05
|
|
|
PITX3
|
[NCBI]
|
3.21583e-05
|
|
|
ASPM
|
[NCBI]
|
3.21583e-05
|
|
|
SCN8A
|
[NCBI]
|
3.21583e-05
|
|
|
KCNQ4
|
[NCBI]
|
3.21583e-05
|
|
|
BFSP2
|
[NCBI]
|
3.21583e-05
|
|
|
OR1F1
|
[NCBI]
|
3.20231e-05
|
|
|
CYP4F22
|
[NCBI]
|
3.20231e-05
|
|
|
CACNA2D3
|
[NCBI]
|
3.20231e-05
|
|
|
pantothenate kinase 3
|
[NCBI]
|
3.20231e-05
|
|
|
radial ray deficiency, x-linked
|
[NCBI]
|
3.20231e-05
|
|
|
C9ORF103
|
[NCBI]
|
3.20231e-05
|
|
|
TTC12
|
[NCBI]
|
3.20231e-05
|
|
|
CRYL1
|
[NCBI]
|
3.20231e-05
|
|
|
PABPC5
|
[NCBI]
|
3.20231e-05
|
|
|
RGSL1
|
[NCBI]
|
3.20231e-05
|
|
|
SUV420H1
|
[NCBI]
|
3.20231e-05
|
|
|
EBF3
|
[NCBI]
|
3.20231e-05
|
|
|
RASEF
|
[NCBI]
|
3.20231e-05
|
|
|
KCNA10
|
[NCBI]
|
3.20231e-05
|
|
|
mental retardation, x-linked, with short stature
|
[NCBI]
|
3.20231e-05
|
|
|
ZNF193
|
[NCBI]
|
3.20231e-05
|
|
|
C9ORF64
|
[NCBI]
|
3.20231e-05
|
|
|
narcolepsy candidate region gene 1a
|
[NCBI]
|
3.20231e-05
|
|
|
RGSL2
|
[NCBI]
|
3.20231e-05
|
|
|
pantothenate kinase 1
|
[NCBI]
|
3.20231e-05
|
|
|
C11ORF24
|
[NCBI]
|
3.20231e-05
|
|
|
TUSC1
|
[NCBI]
|
3.20231e-05
|
|
|
MPZL3
|
[NCBI]
|
3.20231e-05
|
|
|
IL1RL2
|
[NCBI]
|
3.20231e-05
|
|
|
ZNF192
|
[NCBI]
|
3.20231e-05
|
|
|
GNA14
|
[NCBI]
|
3.20231e-05
|
|
|
LY6G6D
|
[NCBI]
|
3.20231e-05
|
|
|
mental retardation, x-linked, south african type
|
[NCBI]
|
3.20231e-05
|
|
|
ST11
|
[NCBI]
|
3.20231e-05
|
|
|
BRAF
|
[NCBI]
|
3.16603e-05
|
|
|
corneal dystrophy, crystalline, of schnyder
|
[NCBI]
|
3.14753e-05
|
|
|
PARK3
|
[NCBI]
|
3.14753e-05
|
|
|
WM1
|
[NCBI]
|
3.14753e-05
|
|
|
TOC
|
[NCBI]
|
3.14753e-05
|
|
|
CLCN7
|
[NCBI]
|
3.11477e-05
|
|
|
CRYGC
|
[NCBI]
|
3.11477e-05
|
|
|
LEPR
|
[NCBI]
|
3.08308e-05
|
|
|
AFP
|
[NCBI]
|
3.06006e-05
|
|
|
LDLR
|
[NCBI]
|
3.04265e-05
|
|
|
CA4
|
[NCBI]
|
3.02207e-05
|
|
|
SRA2
|
[NCBI]
|
3.02207e-05
|
|
|
HLA-C
|
[NCBI]
|
3.02207e-05
|
|
|
IFNG
|
[NCBI]
|
3.01991e-05
|
|
|
WBS
|
[NCBI]
|
3.00231e-05
|
|
|
NPPA
|
[NCBI]
|
2.98081e-05
|
|
|
EVC
|
[NCBI]
|
2.95601e-05
|
|
|
OPTB1
|
[NCBI]
|
2.95601e-05
|
|
|
FHM1
|
[NCBI]
|
2.95601e-05
|
|
|
MSTN
|
[NCBI]
|
2.95174e-05
|
|
|
l-2-hydroxyglutaric aciduria
|
[NCBI]
|
2.94998e-05
|
|
|
sarcosinemia
|
[NCBI]
|
2.94998e-05
|
|
|
DFNB18
|
[NCBI]
|
2.94998e-05
|
|
|
LIS2
|
[NCBI]
|
2.94998e-05
|
|
|
DFNB10
|
[NCBI]
|
2.94998e-05
|
|
|
CNA2
|
[NCBI]
|
2.94998e-05
|
|
|
MRXSL
|
[NCBI]
|
2.94998e-05
|
|
|
RP14
|
[NCBI]
|
2.94998e-05
|
|
|
stickler syndrome, type i, nonsyndromic ocular
|
[NCBI]
|
2.94998e-05
|
|
|
DFNB8
|
[NCBI]
|
2.94998e-05
|
|
|
uniparental disomy, paternal, chromosome 14
|
[NCBI]
|
2.94998e-05
|
|
|
noonan-like/multiple giant cell lesion syndrome
|
[NCBI]
|
2.94998e-05
|
|
|
SPG13
|
[NCBI]
|
2.94998e-05
|
|
|
cataract, lamellar
|
[NCBI]
|
2.94998e-05
|
|
|
EVR4
|
[NCBI]
|
2.94998e-05
|
|
|
UL
|
[NCBI]
|
2.94998e-05
|
|
|
PBC
|
[NCBI]
|
2.94998e-05
|
|
|
ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant
|
[NCBI]
|
2.94998e-05
|
|
|
CRYGD
|
[NCBI]
|
2.93646e-05
|
|
|
POMT1
|
[NCBI]
|
2.85697e-05
|
|
|
NRG1
|
[NCBI]
|
2.84095e-05
|
|
|
PANK2
|
[NCBI]
|
2.78281e-05
|
|
|
PLA2G2A
|
[NCBI]
|
2.78281e-05
|
|
|
ELAC2
|
[NCBI]
|
2.78281e-05
|
|
|
CRYBB2
|
[NCBI]
|
2.78281e-05
|
|
|
STGD1
|
[NCBI]
|
2.72641e-05
|
|
|
CBFA2T1
|
[NCBI]
|
2.71332e-05
|
|
|
USH2A
|
[NCBI]
|
2.71332e-05
|
|
|
migraine with or without aura, susceptibility to, 1
|
[NCBI]
|
2.69713e-05
|
|
|
RP
|
[NCBI]
|
2.64956e-05
|
|
|
cerebral palsy, spastic, symmetric, autosomal recessive
|
[NCBI]
|
2.64826e-05
|
|
|
CLN6
|
[NCBI]
|
2.64826e-05
|
|
|
avascular necrosis of femoral head, primary
|
[NCBI]
|
2.64826e-05
|
|
|
HMS
|
[NCBI]
|
2.64826e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate b
|
[NCBI]
|
2.64826e-05
|
|
|
CCM3
|
[NCBI]
|
2.64826e-05
|
|
|
SPMM
|
[NCBI]
|
2.64826e-05
|
|
|
hypotrichosis simplex of scalp
|
[NCBI]
|
2.64826e-05
|
|
|
CPVT
|
[NCBI]
|
2.64826e-05
|
|
|
SCA5
|
[NCBI]
|
2.64826e-05
|
|
|
MPD1
|
[NCBI]
|
2.64826e-05
|
|
|
NEM2
|
[NCBI]
|
2.64826e-05
|
|
|
wolfram syndrome, mitochondrial form
|
[NCBI]
|
2.64826e-05
|
|
|
endometrial cancer
|
[NCBI]
|
2.64826e-05
|
|
|
GBS
|
[NCBI]
|
2.64826e-05
|
|
|
DSAP1
|
[NCBI]
|
2.64826e-05
|
|
|
HGPPS
|
[NCBI]
|
2.64826e-05
|
|
|
acromesomelic dysplasia, hunter-thompson type
|
[NCBI]
|
2.64826e-05
|
|
|
thyrotoxic periodic paralysis
|
[NCBI]
|
2.64826e-05
|
|
|
ARMD7
|
[NCBI]
|
2.64826e-05
|
|
|
LSFC
|
[NCBI]
|
2.64826e-05
|
|
|
FOXC1
|
[NCBI]
|
2.64797e-05
|
|
|
STL1
|
[NCBI]
|
2.61948e-05
|
|
|
GUCY2D
|
[NCBI]
|
2.58632e-05
|
|
|
TERF2
|
[NCBI]
|
2.58632e-05
|
|
|
HMOX1
|
[NCBI]
|
2.58632e-05
|
|
|
MAPT
|
[NCBI]
|
2.57771e-05
|
|
|
EIG
|
[NCBI]
|
2.57758e-05
|
|
|
porphyria variegata
|
[NCBI]
|
2.52061e-05
|
|
|
ELN
|
[NCBI]
|
2.4955e-05
|
|
|
HR
|
[NCBI]
|
2.4726e-05
|
|
|
CLCN5
|
[NCBI]
|
2.4726e-05
|
|
|
GJB6
|
[NCBI]
|
2.4726e-05
|
|
|
DCX
|
[NCBI]
|
2.4726e-05
|
|
|
ASIP
|
[NCBI]
|
2.41995e-05
|
|
|
MC2R
|
[NCBI]
|
2.41995e-05
|
|
|
TRMA
|
[NCBI]
|
2.39482e-05
|
|
|
citrullinemia, type ii, neonatal-onset
|
[NCBI]
|
2.39482e-05
|
|
|
NPHP2
|
[NCBI]
|
2.39482e-05
|
|
|
EBS-MP
|
[NCBI]
|
2.39482e-05
|
|
|
HRD
|
[NCBI]
|
2.39482e-05
|
|
|
rheumatoid arthritis, systemic juvenile
|
[NCBI]
|
2.39482e-05
|
|
|
IBM3
|
[NCBI]
|
2.39482e-05
|
|
|
colorectal adenomatous polyposis, autosomal recessive
|
[NCBI]
|
2.39482e-05
|
|
|
mast cell disease
|
[NCBI]
|
2.39482e-05
|
|
|
monosomy 1p36 syndrome
|
[NCBI]
|
2.39482e-05
|
|
|
ear wax, wet/dry
|
[NCBI]
|
2.39482e-05
|
|
|
vacterl association with hydrocephalus, x-linked
|
[NCBI]
|
2.39482e-05
|
|
|
psoriatic arthritis, susceptibility to
|
[NCBI]
|
2.39482e-05
|
|
|
ODG2
|
[NCBI]
|
2.39482e-05
|
|
|
IBMPFD
|
[NCBI]
|
2.39482e-05
|
|
|
MCOPS2
|
[NCBI]
|
2.39482e-05
|
|
|
MCKD2
|
[NCBI]
|
2.39482e-05
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
2.39482e-05
|
|
|
PARK4
|
[NCBI]
|
2.39482e-05
|
|
|
MRX9
|
[NCBI]
|
2.39482e-05
|
|
|
EPD
|
[NCBI]
|
2.39482e-05
|
|
|
SLEB1
|
[NCBI]
|
2.39482e-05
|
|
|
CMT4B1
|
[NCBI]
|
2.39482e-05
|
|
|
epiphyseal dysplasia, multiple, with early-onset diabetes mellitus
|
[NCBI]
|
2.39482e-05
|
|
|
GKAP1
|
[NCBI]
|
2.38029e-05
|
|
|
downregulated in renal cell carcinoma 1
|
[NCBI]
|
2.38029e-05
|
|
|
PTCHD2
|
[NCBI]
|
2.38029e-05
|
|
|
KRTHB5
|
[NCBI]
|
2.38029e-05
|
|
|
GPR19
|
[NCBI]
|
2.38029e-05
|
|
|
PRCD
|
[NCBI]
|
2.38029e-05
|
|
|
ZFAT1
|
[NCBI]
|
2.38029e-05
|
|
|
BCL7B
|
[NCBI]
|
2.38029e-05
|
|
|
NDUFV3
|
[NCBI]
|
2.38029e-05
|
|
|
DNAJC19
|
[NCBI]
|
2.38029e-05
|
|
|
TM7SF2
|
[NCBI]
|
2.38029e-05
|
|
|
leucyl-trna synthetase, mitochondrial
|
[NCBI]
|
2.38029e-05
|
|
|
TP53I3
|
[NCBI]
|
2.38029e-05
|
|
|
SASH1
|
[NCBI]
|
2.38029e-05
|
|
|
ZNF674
|
[NCBI]
|
2.38029e-05
|
|
|
TBL2
|
[NCBI]
|
2.38029e-05
|
|
|
TBCD
|
[NCBI]
|
2.38029e-05
|
|
|
DSPG3
|
[NCBI]
|
2.38029e-05
|
|
|
MASTL
|
[NCBI]
|
2.38029e-05
|
|
|
abl interactor 2
|
[NCBI]
|
2.38029e-05
|
|
|
ZNF165
|
[NCBI]
|
2.38029e-05
|
|
|
BAT2
|
[NCBI]
|
2.38029e-05
|
|
|
TMPRSS11E
|
[NCBI]
|
2.38029e-05
|
|
|
TUSC3
|
[NCBI]
|
2.38029e-05
|
|
|
SSBP1
|
[NCBI]
|
2.38029e-05
|
|
|
g6b protein
|
[NCBI]
|
2.38029e-05
|
|
|
PANK4
|
[NCBI]
|
2.38029e-05
|
|
|
cytochrome p450, family 4, subfamily v, polypeptide 2
|
[NCBI]
|
2.38029e-05
|
|
|
VAMP2
|
[NCBI]
|
2.36976e-05
|
|
|
RPE65
|
[NCBI]
|
2.36976e-05
|
|
|
PKS
|
[NCBI]
|
2.32611e-05
|
|
|
SPG3A
|
[NCBI]
|
2.32611e-05
|
|
|
PARK2
|
[NCBI]
|
2.32611e-05
|
|
|
HSR
|
[NCBI]
|
2.32182e-05
|
|
|
MFN2
|
[NCBI]
|
2.32182e-05
|
|
|
IRF1
|
[NCBI]
|
2.32182e-05
|
|
|
KLF6
|
[NCBI]
|
2.27596e-05
|
|
|
PARK2
|
[NCBI]
|
2.24847e-05
|
|
|
EXT1
|
[NCBI]
|
2.232e-05
|
|
|
SCN1A
|
[NCBI]
|
2.232e-05
|
|
|
GIST
|
[NCBI]
|
2.19173e-05
|
|
|
EYA1
|
[NCBI]
|
2.18981e-05
|
|
|
currarino syndrome
|
[NCBI]
|
2.17749e-05
|
|
|
HMN2A
|
[NCBI]
|
2.17749e-05
|
|
|
OPTA2
|
[NCBI]
|
2.17749e-05
|
|
|
INAD1
|
[NCBI]
|
2.17749e-05
|
|
|
fundus albipunctatus
|
[NCBI]
|
2.17749e-05
|
|
|
FTC
|
[NCBI]
|
2.17749e-05
|
|
|
HFE3
|
[NCBI]
|
2.17749e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, lethal neonatal
|
[NCBI]
|
2.17749e-05
|
|
|
ADHR
|
[NCBI]
|
2.17749e-05
|
|
|
SBS
|
[NCBI]
|
2.17749e-05
|
|
|
MODY2
|
[NCBI]
|
2.17749e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 1
|
[NCBI]
|
2.17749e-05
|
|
|
CMT4B2
|
[NCBI]
|
2.17749e-05
|
|
|
HHF6
|
[NCBI]
|
2.17749e-05
|
|
|
3-@methylglutaconic aciduria, type i
|
[NCBI]
|
2.17749e-05
|
|
|
EGFR
|
[NCBI]
|
2.16279e-05
|
|
|
MM
|
[NCBI]
|
2.1506e-05
|
|
|
walker-warburg syndrome
|
[NCBI]
|
2.1506e-05
|
|
|
campomelic dysplasia
|
[NCBI]
|
2.1506e-05
|
|
|
SLC17A7
|
[NCBI]
|
2.14926e-05
|
|
|
GJA8
|
[NCBI]
|
2.14926e-05
|
|
|
TIMP3
|
[NCBI]
|
2.14926e-05
|
|
|
IFNGR1
|
[NCBI]
|
2.14926e-05
|
|
|
PTCH1
|
[NCBI]
|
2.14926e-05
|
|
|
HMGA2
|
[NCBI]
|
2.11022e-05
|
|
|
KRT14
|
[NCBI]
|
2.11022e-05
|
|
|
PD
|
[NCBI]
|
2.10103e-05
|
|
|
TNFSF6
|
[NCBI]
|
2.08776e-05
|
|
|
TTN
|
[NCBI]
|
2.07261e-05
|
|
|
DISC1
|
[NCBI]
|
2.07261e-05
|
|
|
XPC
|
[NCBI]
|
2.07261e-05
|
|
|
NOS2A
|
[NCBI]
|
2.07261e-05
|
|
|
LIMD1
|
[NCBI]
|
2.07172e-05
|
|
|
SAPS3
|
[NCBI]
|
2.07172e-05
|
|
|
FXYD6
|
[NCBI]
|
2.07172e-05
|
|
|
NDUFA8
|
[NCBI]
|
2.07172e-05
|
|
|
TTBK2
|
[NCBI]
|
2.07172e-05
|
|
|
kinesin family member 27, kif27
|
[NCBI]
|
2.07172e-05
|
|
|
POMT2
|
[NCBI]
|
2.07172e-05
|
|
|
C11ORF5
|
[NCBI]
|
2.07172e-05
|
|
|
IL18R1
|
[NCBI]
|
2.07172e-05
|
|
|
NUP62
|
[NCBI]
|
2.07172e-05
|
|
|
androgen-induced prostate proliferative shutoff-associated protein
|
[NCBI]
|
2.07172e-05
|
|
|
RAPGEF1
|
[NCBI]
|
2.07172e-05
|
|
|
DPP10
|
[NCBI]
|
2.07172e-05
|
|
|
TTC3
|
[NCBI]
|
2.07172e-05
|
|
|
ZNF200
|
[NCBI]
|
2.07172e-05
|
|
|
AMPD3
|
[NCBI]
|
2.07172e-05
|
|
|
PDCD10
|
[NCBI]
|
2.07172e-05
|
|
|
ZNF169
|
[NCBI]
|
2.07172e-05
|
|
|
EVER2
|
[NCBI]
|
2.07172e-05
|
|
|
DMRT2
|
[NCBI]
|
2.07172e-05
|
|
|
ASCC3L1
|
[NCBI]
|
2.07172e-05
|
|
|
ATP6V0A4
|
[NCBI]
|
2.07172e-05
|
|
|
USP25
|
[NCBI]
|
2.07172e-05
|
|
|
SGPL1
|
[NCBI]
|
2.07172e-05
|
|
|
BARHL1
|
[NCBI]
|
2.07172e-05
|
|
|
CMTX1
|
[NCBI]
|
2.06816e-05
|
|
|
OPA1
|
[NCBI]
|
2.06816e-05
|
|
|
RBP4
|
[NCBI]
|
2.03631e-05
|
|
|
CSTB
|
[NCBI]
|
2.03631e-05
|
|
|
CEACAM5
|
[NCBI]
|
2.0094e-05
|
|
|
MEFV
|
[NCBI]
|
2.00126e-05
|
|
|
DCN
|
[NCBI]
|
2.00126e-05
|
|
|
SMAD4
|
[NCBI]
|
2.00126e-05
|
|
|
COH1
|
[NCBI]
|
1.98899e-05
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
1.98899e-05
|
|
|
NETH
|
[NCBI]
|
1.98818e-05
|
|
|
PARK1
|
[NCBI]
|
1.98818e-05
|
|
|
schwannomatosis
|
[NCBI]
|
1.98818e-05
|
|
|
LISX1
|
[NCBI]
|
1.98818e-05
|
|
|
USH1D
|
[NCBI]
|
1.98818e-05
|
|
|
renal tubular acidosis, distal, with progressive nerve deafness
|
[NCBI]
|
1.98818e-05
|
|
|
HFE4
|
[NCBI]
|
1.98818e-05
|
|
|
lymphedema, hereditary, i
|
[NCBI]
|
1.98818e-05
|
|
|
corneal dystrophy, gelatinous drop-like
|
[NCBI]
|
1.98818e-05
|
|
|
epstein syndrome
|
[NCBI]
|
1.98818e-05
|
|
|
CTLN2
|
[NCBI]
|
1.98818e-05
|
|
|
WZS
|
[NCBI]
|
1.98818e-05
|
|
|
NYS1
|
[NCBI]
|
1.98818e-05
|
|
|
CLN8
|
[NCBI]
|
1.98818e-05
|
|
|
CMT4C
|
[NCBI]
|
1.98818e-05
|
|
|
DFNA2
|
[NCBI]
|
1.98818e-05
|
|
|
glycogen storage disease ic
|
[NCBI]
|
1.98818e-05
|
|
|
FASN
|
[NCBI]
|
1.96737e-05
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
1.91292e-05
|
|
|
PDS
|
[NCBI]
|
1.91292e-05
|
|
|
CTNS
|
[NCBI]
|
1.91292e-05
|
|
|
PPOX
|
[NCBI]
|
1.90281e-05
|
|
|
ATBF1
|
[NCBI]
|
1.8723e-05
|
|
|
RMI1
|
[NCBI]
|
1.8723e-05
|
|
|
JMJD3
|
[NCBI]
|
1.8723e-05
|
|
|
SNAP29
|
[NCBI]
|
1.8723e-05
|
|
|
IL1R2
|
[NCBI]
|
1.8723e-05
|
|
|
SLITRK1
|
[NCBI]
|
1.8723e-05
|
|
|
MINK1
|
[NCBI]
|
1.8723e-05
|
|
|
KLK12
|
[NCBI]
|
1.8723e-05
|
|
|
PLEKHG4
|
[NCBI]
|
1.8723e-05
|
|
|
BBS2
|
[NCBI]
|
1.8723e-05
|
|
|
TCAP
|
[NCBI]
|
1.8723e-05
|
|
|
USH1G
|
[NCBI]
|
1.8723e-05
|
|
|
ARFGEF2
|
[NCBI]
|
1.8723e-05
|
|
|
OSR2
|
[NCBI]
|
1.8723e-05
|
|
|
EVER1
|
[NCBI]
|
1.8723e-05
|
|
|
COL8A2
|
[NCBI]
|
1.8723e-05
|
|
|
PPT2
|
[NCBI]
|
1.8723e-05
|
|
|
KLK11
|
[NCBI]
|
1.8723e-05
|
|
|
NEF3
|
[NCBI]
|
1.8723e-05
|
|
|
ING3
|
[NCBI]
|
1.8723e-05
|
|
|
PCM1
|
[NCBI]
|
1.8723e-05
|
|
|
TLE4
|
[NCBI]
|
1.8723e-05
|
|
|
RNF6
|
[NCBI]
|
1.8723e-05
|
|
|
CXCL14
|
[NCBI]
|
1.8723e-05
|
|
|
SLC28A3
|
[NCBI]
|
1.8723e-05
|
|
|
CCDC50
|
[NCBI]
|
1.8723e-05
|
|
|
ZNF81
|
[NCBI]
|
1.8723e-05
|
|
|
RPL28
|
[NCBI]
|
1.8723e-05
|
|
|
PHF11
|
[NCBI]
|
1.8723e-05
|
|
|
POU6F2
|
[NCBI]
|
1.8723e-05
|
|
|
ADRBK2
|
[NCBI]
|
1.8723e-05
|
|
|
GAPDHS
|
[NCBI]
|
1.8723e-05
|
|
|
CTDSPL
|
[NCBI]
|
1.8723e-05
|
|
|
L2HGDH
|
[NCBI]
|
1.8723e-05
|
|
|
JRK
|
[NCBI]
|
1.8723e-05
|
|
|
FHIT
|
[NCBI]
|
1.87202e-05
|
|
|
TYRP1
|
[NCBI]
|
1.87202e-05
|
|
|
BDC
|
[NCBI]
|
1.82125e-05
|
|
|
IRID1
|
[NCBI]
|
1.82125e-05
|
|
|
BDA1
|
[NCBI]
|
1.82125e-05
|
|
|
BOS1
|
[NCBI]
|
1.82125e-05
|
|
|
wagr syndrome
|
[NCBI]
|
1.82125e-05
|
|
|
GVM
|
[NCBI]
|
1.82125e-05
|
|
|
OSMED
|
[NCBI]
|
1.82125e-05
|
|
|
SLSN1
|
[NCBI]
|
1.82125e-05
|
|
|
CMT2A2
|
[NCBI]
|
1.82125e-05
|
|
|
ichthyosis vulgaris
|
[NCBI]
|
1.82125e-05
|
|
|
DFNA12
|
[NCBI]
|
1.82125e-05
|
|
|
SLC26A4
|
[NCBI]
|
1.81315e-05
|
|
|
G6PD
|
[NCBI]
|
1.80238e-05
|
|
|
LMNA
|
[NCBI]
|
1.79735e-05
|
|
|
AHO
|
[NCBI]
|
1.78901e-05
|
|
|
RS1
|
[NCBI]
|
1.78497e-05
|
|
|
OPTN
|
[NCBI]
|
1.78497e-05
|
|
|
POAG
|
[NCBI]
|
1.76942e-05
|
|
|
FOP
|
[NCBI]
|
1.76942e-05
|
|
|
DES
|
[NCBI]
|
1.73093e-05
|
|
|
STK11
|
[NCBI]
|
1.73093e-05
|
|
|
TNFRSF1B
|
[NCBI]
|
1.73093e-05
|
|
|
ATP7B
|
[NCBI]
|
1.73093e-05
|
|
|
EDN1
|
[NCBI]
|
1.73093e-05
|
|
|
LILRA2
|
[NCBI]
|
1.72472e-05
|
|
|
FOXE3
|
[NCBI]
|
1.72472e-05
|
|
|
SLC34A2
|
[NCBI]
|
1.72472e-05
|
|
|
FANCF
|
[NCBI]
|
1.72472e-05
|
|
|
SARDH
|
[NCBI]
|
1.72472e-05
|
|
|
GLMN
|
[NCBI]
|
1.72472e-05
|
|
|
FXYD2
|
[NCBI]
|
1.72472e-05
|
|
|
ABCC11
|
[NCBI]
|
1.72472e-05
|
|
|
g30 gene
|
[NCBI]
|
1.72472e-05
|
|
|
TGM5
|
[NCBI]
|
1.72472e-05
|
|
|
NFKBIL1
|
[NCBI]
|
1.72472e-05
|
|
|
BRSK2
|
[NCBI]
|
1.72472e-05
|
|
|
DBC1
|
[NCBI]
|
1.72472e-05
|
|
|
CRYGS
|
[NCBI]
|
1.72472e-05
|
|
|
NTSR1
|
[NCBI]
|
1.72472e-05
|
|
|
PHF8
|
[NCBI]
|
1.72472e-05
|
|
|
BFSP1
|
[NCBI]
|
1.72472e-05
|
|
|
SNF1LK2
|
[NCBI]
|
1.72472e-05
|
|
|
PHF6
|
[NCBI]
|
1.72472e-05
|
|
|
EVC
|
[NCBI]
|
1.72472e-05
|
|
|
NAPA
|
[NCBI]
|
1.72472e-05
|
|
|
AP1S2
|
[NCBI]
|
1.72472e-05
|
|
|
EDD1
|
[NCBI]
|
1.72472e-05
|
|
|
EPIM
|
[NCBI]
|
1.72472e-05
|
|
|
PRDM2
|
[NCBI]
|
1.72472e-05
|
|
|
CSNK1E
|
[NCBI]
|
1.72472e-05
|
|
|
STX16
|
[NCBI]
|
1.72472e-05
|
|
|
ROBO3
|
[NCBI]
|
1.72472e-05
|
|
|
ATXN10
|
[NCBI]
|
1.72472e-05
|
|
|
SLC7A2
|
[NCBI]
|
1.72472e-05
|
|
|
IRAK3
|
[NCBI]
|
1.72472e-05
|
|
|
CDSP
|
[NCBI]
|
1.70169e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
1.70133e-05
|
|
|
FRNS
|
[NCBI]
|
1.69575e-05
|
|
|
ABCA4
|
[NCBI]
|
1.67972e-05
|
|
|
SACS
|
[NCBI]
|
1.67263e-05
|
|
|
CMT4A
|
[NCBI]
|
1.67263e-05
|
|
|
SEDT
|
[NCBI]
|
1.67263e-05
|
|
|
HRPT2
|
[NCBI]
|
1.67263e-05
|
|
|
leiomyoma, hereditary multiple, of skin
|
[NCBI]
|
1.67263e-05
|
|
|
LGMD2H
|
[NCBI]
|
1.67263e-05
|
|
|
CLN5
|
[NCBI]
|
1.67263e-05
|
|
|
PPD2
|
[NCBI]
|
1.67263e-05
|
|
|
SOX9
|
[NCBI]
|
1.63109e-05
|
|
|
telomere length, mean leukocyte
|
[NCBI]
|
1.62643e-05
|
|
|
DAZ
|
[NCBI]
|
1.60767e-05
|
|
|
KLK8
|
[NCBI]
|
1.60766e-05
|
|
|
SBF2
|
[NCBI]
|
1.60766e-05
|
|
|
EIF2B4
|
[NCBI]
|
1.60766e-05
|
|
|
TGM3
|
[NCBI]
|
1.60766e-05
|
|
|
SLC22A12
|
[NCBI]
|
1.60766e-05
|
|
|
FTSJ1
|
[NCBI]
|
1.60766e-05
|
|
|
TLE1
|
[NCBI]
|
1.60766e-05
|
|
|
PLOD3
|
[NCBI]
|
1.60766e-05
|
|
|
HSN2
|
[NCBI]
|
1.60766e-05
|
|
|
EHD1
|
[NCBI]
|
1.60766e-05
|
|
|
MTMR1
|
[NCBI]
|
1.60766e-05
|
|
|
switch-associated protein 70
|
[NCBI]
|
1.60766e-05
|
|
|
SLC4A11
|
[NCBI]
|
1.60766e-05
|
|
|
RFXANK
|
[NCBI]
|
1.60766e-05
|
|
|
DDX11
|
[NCBI]
|
1.60766e-05
|
|
|
MOCS1
|
[NCBI]
|
1.60766e-05
|
|
|
NLRP7
|
[NCBI]
|
1.60766e-05
|
|
|
RNF139
|
[NCBI]
|
1.60766e-05
|
|
|
NPHP3
|
[NCBI]
|
1.60766e-05
|
|
|
SCAMP1
|
[NCBI]
|
1.60766e-05
|
|
|
COH1
|
[NCBI]
|
1.60766e-05
|
|
|
PLUNC
|
[NCBI]
|
1.60766e-05
|
|
|
NTF5
|
[NCBI]
|
1.60766e-05
|
|
|
PLA2G1B
|
[NCBI]
|
1.60766e-05
|
|
|
P2RX4
|
[NCBI]
|
1.60766e-05
|
|
|
g72 gene
|
[NCBI]
|
1.60766e-05
|
|
|
CNTN4
|
[NCBI]
|
1.60766e-05
|
|
|
CRMP1
|
[NCBI]
|
1.60766e-05
|
|
|
WBSCR14
|
[NCBI]
|
1.60766e-05
|
|
|
SEC23A
|
[NCBI]
|
1.60766e-05
|
|
|
HNRNPK
|
[NCBI]
|
1.60766e-05
|
|
|
RELN
|
[NCBI]
|
1.58481e-05
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
1.57364e-05
|
|
|
BMP4
|
[NCBI]
|
1.56996e-05
|
|
|
CTSC
|
[NCBI]
|
1.5625e-05
|
|
|
NM
|
[NCBI]
|
1.53924e-05
|
|
|
KFSD
|
[NCBI]
|
1.53924e-05
|
|
|
chromosome 22q13.3 deletion syndrome
|
[NCBI]
|
1.53924e-05
|
|
|
SHEP1
|
[NCBI]
|
1.53924e-05
|
|
|
ACCPN
|
[NCBI]
|
1.53924e-05
|
|
|
monilethrix
|
[NCBI]
|
1.53924e-05
|
|
|
mulibrey nanism
|
[NCBI]
|
1.53924e-05
|
|
|
autoimmune disease
|
[NCBI]
|
1.53924e-05
|
|
|
AEZ
|
[NCBI]
|
1.53924e-05
|
|
|
PKD1
|
[NCBI]
|
1.53391e-05
|
|
|
CLCN3
|
[NCBI]
|
1.51078e-05
|
|
|
PTBP1
|
[NCBI]
|
1.51078e-05
|
|
|
NHS
|
[NCBI]
|
1.51078e-05
|
|
|
PMX1
|
[NCBI]
|
1.51078e-05
|
|
|
CHD7
|
[NCBI]
|
1.51078e-05
|
|
|
SPAG11
|
[NCBI]
|
1.51078e-05
|
|
|
MUC3A
|
[NCBI]
|
1.51078e-05
|
|
|
CRYBA4
|
[NCBI]
|
1.51078e-05
|
|
|
MEOX1
|
[NCBI]
|
1.51078e-05
|
|
|
TCF8
|
[NCBI]
|
1.51078e-05
|
|
|
TMEFF2
|
[NCBI]
|
1.51078e-05
|
|
|
PRSS12
|
[NCBI]
|
1.51078e-05
|
|
|
IL1R1
|
[NCBI]
|
1.51078e-05
|
|
|
GAB1
|
[NCBI]
|
1.51078e-05
|
|
|
CLN8
|
[NCBI]
|
1.51078e-05
|
|
|
ATP2C1
|
[NCBI]
|
1.51078e-05
|
|
|
ARIX
|
[NCBI]
|
1.51078e-05
|
|
|
HLA-F
|
[NCBI]
|
1.51078e-05
|
|
|
RENBP
|
[NCBI]
|
1.51078e-05
|
|
|
HSPB8
|
[NCBI]
|
1.51078e-05
|
|
|
CRYM
|
[NCBI]
|
1.51078e-05
|
|
|
SATB2
|
[NCBI]
|
1.51078e-05
|
|
|
NPHP4
|
[NCBI]
|
1.51078e-05
|
|
|
CVID
|
[NCBI]
|
1.50862e-05
|
|
|
PCD
|
[NCBI]
|
1.50515e-05
|
|
|
DFSP
|
[NCBI]
|
1.46906e-05
|
|
|
CDKN2A
|
[NCBI]
|
1.46497e-05
|
|
|
FA
|
[NCBI]
|
1.45566e-05
|
|
|
DYT1
|
[NCBI]
|
1.4547e-05
|
|
|
sotos syndrome
|
[NCBI]
|
1.4547e-05
|
|
|
ALGS1
|
[NCBI]
|
1.4547e-05
|
|
|
aortic valve disease
|
[NCBI]
|
1.4547e-05
|
|
|
MBP
|
[NCBI]
|
1.45243e-05
|
|
|
FLNA
|
[NCBI]
|
1.43876e-05
|
|
|
RLBP1
|
[NCBI]
|
1.43876e-05
|
|
|
AGT
|
[NCBI]
|
1.43876e-05
|
|
|
TLR2
|
[NCBI]
|
1.42893e-05
|
|
|
CLCN4
|
[NCBI]
|
1.42824e-05
|
|
|
NDUFS4
|
[NCBI]
|
1.42824e-05
|
|
|
NIPBL
|
[NCBI]
|
1.42824e-05
|
|
|
DMRT1
|
[NCBI]
|
1.42824e-05
|
|
|
KLK5
|
[NCBI]
|
1.42824e-05
|
|
|
CCHCR1
|
[NCBI]
|
1.42824e-05
|
|
|
CUL4B
|
[NCBI]
|
1.42824e-05
|
|
|
HLXB9
|
[NCBI]
|
1.42824e-05
|
|
|
TBX4
|
[NCBI]
|
1.42824e-05
|
|
|
SLC39A4
|
[NCBI]
|
1.42824e-05
|
|
|
CLCN2
|
[NCBI]
|
1.42824e-05
|
|
|
PTGFR
|
[NCBI]
|
1.42824e-05
|
|
|
GALR2
|
[NCBI]
|
1.42824e-05
|
|
|
VKORC1
|
[NCBI]
|
1.42824e-05
|
|
|
ALX4
|
[NCBI]
|
1.42824e-05
|
|
|
ADORA1
|
[NCBI]
|
1.42824e-05
|
|
|
CRYBB1
|
[NCBI]
|
1.42824e-05
|
|
|
CENPJ
|
[NCBI]
|
1.42824e-05
|
|
|
HES1
|
[NCBI]
|
1.42824e-05
|
|
|
KIF1B
|
[NCBI]
|
1.42824e-05
|
|
|
FANCE
|
[NCBI]
|
1.42824e-05
|
|
|
EVPL
|
[NCBI]
|
1.42824e-05
|
|
|
CNGA3
|
[NCBI]
|
1.42824e-05
|
|
|
GNAT2
|
[NCBI]
|
1.42824e-05
|
|
|
EVC2
|
[NCBI]
|
1.42824e-05
|
|
|
AURKC
|
[NCBI]
|
1.42824e-05
|
|
|
CD
|
[NCBI]
|
1.42017e-05
|
|
|
LGMD2I
|
[NCBI]
|
1.41873e-05
|
|
|
CORDX1
|
[NCBI]
|
1.41873e-05
|
|
|
JME
|
[NCBI]
|
1.41873e-05
|
|
|
JLNS1
|
[NCBI]
|
1.41873e-05
|
|
|
ISS
|
[NCBI]
|
1.41873e-05
|
|
|
WGN1
|
[NCBI]
|
1.41873e-05
|
|
|
ACHM2
|
[NCBI]
|
1.41873e-05
|
|
|
CFEOM1
|
[NCBI]
|
1.41873e-05
|
|
|
LGMD1B
|
[NCBI]
|
1.41873e-05
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
1.41873e-05
|
|
|
RET
|
[NCBI]
|
1.41052e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
1.40491e-05
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
1.39838e-05
|
|
|
AR
|
[NCBI]
|
1.39567e-05
|
|
|
HBFQTL2
|
[NCBI]
|
1.36106e-05
|
|
|
IL1RL1
|
[NCBI]
|
1.35642e-05
|
|
|
FGF20
|
[NCBI]
|
1.35642e-05
|
|
|
ST7
|
[NCBI]
|
1.35642e-05
|
|
|
FGF14
|
[NCBI]
|
1.35642e-05
|
|
|
KRT12
|
[NCBI]
|
1.35642e-05
|
|
|
GCLM
|
[NCBI]
|
1.35642e-05
|
|
|
PITPN
|
[NCBI]
|
1.35642e-05
|
|
|
GRIK1
|
[NCBI]
|
1.35642e-05
|
|
|
EDNRA
|
[NCBI]
|
1.35642e-05
|
|
|
SOD3
|
[NCBI]
|
1.35642e-05
|
|
|
PRG1
|
[NCBI]
|
1.35642e-05
|
|
|
GRHPR
|
[NCBI]
|
1.35642e-05
|
|
|
PTF1A
|
[NCBI]
|
1.35642e-05
|
|
|
TFAP2C
|
[NCBI]
|
1.35642e-05
|
|
|
IRF2
|
[NCBI]
|
1.35642e-05
|
|
|
RPGR
|
[NCBI]
|
1.34707e-05
|
|
|
NPS
|
[NCBI]
|
1.34404e-05
|
|
|
ADLTE
|
[NCBI]
|
1.30926e-05
|
|
|
vitamin d-dependent rickets, type i
|
[NCBI]
|
1.30926e-05
|
|
|
CTHM
|
[NCBI]
|
1.30926e-05
|
|
|
alpha-thalassemia/mental retardation syndrome, deletion-type
|
[NCBI]
|
1.30926e-05
|
|
|
waardenburg-shah syndrome
|
[NCBI]
|
1.30926e-05
|
|
|
potocki-shaffer syndrome
|
[NCBI]
|
1.30926e-05
|
|
|
mowat-wilson syndrome
|
[NCBI]
|
1.30926e-05
|
|
|
ichthyosis congenita, harlequin fetus type
|
[NCBI]
|
1.30926e-05
|
|
|
PPCD1
|
[NCBI]
|
1.30926e-05
|
|
|
danon disease
|
[NCBI]
|
1.30926e-05
|
|
|
LGMD2B
|
[NCBI]
|
1.30926e-05
|
|
|
HMS1
|
[NCBI]
|
1.30926e-05
|
|
|
PKD2
|
[NCBI]
|
1.29626e-05
|
|
|
CEBPE
|
[NCBI]
|
1.29291e-05
|
|
|
IL9R
|
[NCBI]
|
1.29291e-05
|
|
|
MLPH
|
[NCBI]
|
1.29291e-05
|
|
|
LMBR1
|
[NCBI]
|
1.29291e-05
|
|
|
SYN1
|
[NCBI]
|
1.29291e-05
|
|
|
ADSS
|
[NCBI]
|
1.29291e-05
|
|
|
ING1
|
[NCBI]
|
1.29291e-05
|
|
|
EXO1
|
[NCBI]
|
1.29291e-05
|
|
|
CLDN16
|
[NCBI]
|
1.29291e-05
|
|
|
ASPN
|
[NCBI]
|
1.29291e-05
|
|
|
CR2
|
[NCBI]
|
1.29291e-05
|
|
|
PTGER2
|
[NCBI]
|
1.29291e-05
|
|
|
SLC19A2
|
[NCBI]
|
1.29291e-05
|
|
|
HTRA1
|
[NCBI]
|
1.29291e-05
|
|
|
RB1CC1
|
[NCBI]
|
1.29291e-05
|
|
|
EYA2
|
[NCBI]
|
1.29291e-05
|
|
|
CDKL5
|
[NCBI]
|
1.29291e-05
|
|
|
TACSTD2
|
[NCBI]
|
1.29291e-05
|
|
|
BRRS
|
[NCBI]
|
1.2916e-05
|
|
|
NF2
|
[NCBI]
|
1.27996e-05
|
|
|
ITGB3
|
[NCBI]
|
1.27996e-05
|
|
|
HMBS
|
[NCBI]
|
1.24309e-05
|
|
|
obesity
|
[NCBI]
|
1.24098e-05
|
|
|
DEFB4
|
[NCBI]
|
1.23606e-05
|
|
|
NPHP1
|
[NCBI]
|
1.23606e-05
|
|
|
HSD17B10
|
[NCBI]
|
1.23606e-05
|
|
|
NPPB
|
[NCBI]
|
1.23606e-05
|
|
|
AMN
|
[NCBI]
|
1.23606e-05
|
|
|
SGCG
|
[NCBI]
|
1.23606e-05
|
|
|
SGCB
|
[NCBI]
|
1.23606e-05
|
|
|
LAMC1
|
[NCBI]
|
1.23606e-05
|
|
|
CYLD1
|
[NCBI]
|
1.23606e-05
|
|
|
LIM2
|
[NCBI]
|
1.23606e-05
|
|
|
SGKL
|
[NCBI]
|
1.23606e-05
|
|
|
RBBP8
|
[NCBI]
|
1.23606e-05
|
|
|
RORA
|
[NCBI]
|
1.23606e-05
|
|
|
POMGNT1
|
[NCBI]
|
1.23606e-05
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
1.20936e-05
|
|
|
severe combined immunodeficiency with sensitivity to ionizing radiation
|
[NCBI]
|
1.20936e-05
|
|
|
PARK6
|
[NCBI]
|
1.20936e-05
|
|
|
CMDD
|
[NCBI]
|
1.20936e-05
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
1.20936e-05
|
|
|
seckel syndrome 1
|
[NCBI]
|
1.20936e-05
|
|
|
coumarin resistance
|
[NCBI]
|
1.20936e-05
|
|
|
CHS
|
[NCBI]
|
1.19637e-05
|
|
|
CCM
|
[NCBI]
|
1.1921e-05
|
|
|
GAD1
|
[NCBI]
|
1.18464e-05
|
|
|
ACCN3
|
[NCBI]
|
1.18464e-05
|
|
|
EIF2AK3
|
[NCBI]
|
1.18464e-05
|
|
|
loc387715 gene
|
[NCBI]
|
1.18464e-05
|
|
|
NLRP3
|
[NCBI]
|
1.18464e-05
|
|
|
TFAP2B
|
[NCBI]
|
1.18464e-05
|
|
|
IGHMBP2
|
[NCBI]
|
1.18464e-05
|
|
|
CNGB1
|
[NCBI]
|
1.18464e-05
|
|
|
UBQLN1
|
[NCBI]
|
1.18464e-05
|
|
|
MYF5
|
[NCBI]
|
1.18464e-05
|
|
|
SOST
|
[NCBI]
|
1.18464e-05
|
|
|
TRIM24
|
[NCBI]
|
1.18464e-05
|
|
|
RPS12
|
[NCBI]
|
1.18464e-05
|
|
|
SLC7A9
|
[NCBI]
|
1.18464e-05
|
|
|
MCM6
|
[NCBI]
|
1.18464e-05
|
|
|
NNAT
|
[NCBI]
|
1.18464e-05
|
|
|
MERTK
|
[NCBI]
|
1.18464e-05
|
|
|
SHH
|
[NCBI]
|
1.17165e-05
|
|
|
GDNF
|
[NCBI]
|
1.16952e-05
|
|
|
CCR5
|
[NCBI]
|
1.1596e-05
|
|
|
TFE3
|
[NCBI]
|
1.13774e-05
|
|
|
SIX1
|
[NCBI]
|
1.13774e-05
|
|
|
MOG
|
[NCBI]
|
1.13774e-05
|
|
|
IGSF4
|
[NCBI]
|
1.13774e-05
|
|
|
COL6A2
|
[NCBI]
|
1.13774e-05
|
|
|
KIR3DL1
|
[NCBI]
|
1.13774e-05
|
|
|
OCRL
|
[NCBI]
|
1.13774e-05
|
|
|
SPINK5
|
[NCBI]
|
1.13774e-05
|
|
|
OGN
|
[NCBI]
|
1.13774e-05
|
|
|
SGCD
|
[NCBI]
|
1.13774e-05
|
|
|
COL6A3
|
[NCBI]
|
1.13774e-05
|
|
|
LTA4H
|
[NCBI]
|
1.13774e-05
|
|
|
ADD1
|
[NCBI]
|
1.13774e-05
|
|
|
RIMS1
|
[NCBI]
|
1.13774e-05
|
|
|
LCN1
|
[NCBI]
|
1.13774e-05
|
|
|
TREX1
|
[NCBI]
|
1.13774e-05
|
|
|
DRD4
|
[NCBI]
|
1.13202e-05
|
|
|
TSC2
|
[NCBI]
|
1.13202e-05
|
|
|
MKKS
|
[NCBI]
|
1.11782e-05
|
|
|
PHA
|
[NCBI]
|
1.11782e-05
|
|
|
refsum disease
|
[NCBI]
|
1.11782e-05
|
|
|
DHRD
|
[NCBI]
|
1.11782e-05
|
|
|
EEC3
|
[NCBI]
|
1.11782e-05
|
|
|
AHDS
|
[NCBI]
|
1.11782e-05
|
|
|
pituitary dwarfism iii
|
[NCBI]
|
1.11782e-05
|
|
|
SCZD1
|
[NCBI]
|
1.11782e-05
|
|
|
CIPA
|
[NCBI]
|
1.11782e-05
|
|
|
FGFR2
|
[NCBI]
|
1.11456e-05
|
|
|
SOD1
|
[NCBI]
|
1.10553e-05
|
|
|
ST8
|
[NCBI]
|
1.09894e-05
|
|
|
IBGC1
|
[NCBI]
|
1.09894e-05
|
|
|
XRCC2
|
[NCBI]
|
1.09467e-05
|
|
|
GARS
|
[NCBI]
|
1.09467e-05
|
|
|
TCIRG1
|
[NCBI]
|
1.09467e-05
|
|
|
EIF2B5
|
[NCBI]
|
1.09467e-05
|
|
|
LDLRAP1
|
[NCBI]
|
1.09467e-05
|
|
|
GOT1
|
[NCBI]
|
1.09467e-05
|
|
|
HCRTR2
|
[NCBI]
|
1.09467e-05
|
|
|
MSR1
|
[NCBI]
|
1.09467e-05
|
|
|
TCF4
|
[NCBI]
|
1.09467e-05
|
|
|
COL9A1
|
[NCBI]
|
1.09467e-05
|
|
|
FCGR2A
|
[NCBI]
|
1.09467e-05
|
|
|
PDE4D
|
[NCBI]
|
1.09467e-05
|
|
|
ARSA
|
[NCBI]
|
1.09231e-05
|
|
|
PSEN1
|
[NCBI]
|
1.09071e-05
|
|
|
WHS
|
[NCBI]
|
1.0795e-05
|
|
|
CD
|
[NCBI]
|
1.0795e-05
|
|
|
EPM2A
|
[NCBI]
|
1.05488e-05
|
|
|
TECTA
|
[NCBI]
|
1.05488e-05
|
|
|
ETF1
|
[NCBI]
|
1.05488e-05
|
|
|
TNNI3
|
[NCBI]
|
1.05488e-05
|
|
|
GGH
|
[NCBI]
|
1.05488e-05
|
|
|
NOTCH3
|
[NCBI]
|
1.05488e-05
|
|
|
AGTR2
|
[NCBI]
|
1.05488e-05
|
|
|
GRB10
|
[NCBI]
|
1.05488e-05
|
|
|
PRX
|
[NCBI]
|
1.05488e-05
|
|
|
CACNA1F
|
[NCBI]
|
1.05488e-05
|
|
|
apc gene
|
[NCBI]
|
1.0522e-05
|
|
|
SLC11A2
|
[NCBI]
|
1.04223e-05
|
|
|
EAOH
|
[NCBI]
|
1.03366e-05
|
|
|
MNS
|
[NCBI]
|
1.03366e-05
|
|
|
EA2
|
[NCBI]
|
1.03366e-05
|
|
|
SHEP2
|
[NCBI]
|
1.03366e-05
|
|
|
TNFRSF11A
|
[NCBI]
|
1.01793e-05
|
|
|
BMPR2
|
[NCBI]
|
1.01793e-05
|
|
|
TULP1
|
[NCBI]
|
1.01793e-05
|
|
|
SPG3A
|
[NCBI]
|
1.01793e-05
|
|
|
CCKAR
|
[NCBI]
|
1.01793e-05
|
|
|
ALOX5AP
|
[NCBI]
|
1.01793e-05
|
|
|
CTNS
|
[NCBI]
|
1.01793e-05
|
|
|
ME2
|
[NCBI]
|
1.01793e-05
|
|
|
TAP1
|
[NCBI]
|
1.01793e-05
|
|
|
PGK2
|
[NCBI]
|
1.01793e-05
|
|
|
ACTB
|
[NCBI]
|
1.01793e-05
|
|
|
SCA1
|
[NCBI]
|
1.01701e-05
|
|
|
MJD
|
[NCBI]
|
9.98862e-06
|
|
|
COL18A1
|
[NCBI]
|
9.83459e-06
|
|
|
MC3R
|
[NCBI]
|
9.83459e-06
|
|
|
ZEB2
|
[NCBI]
|
9.83459e-06
|
|
|
TXNIP
|
[NCBI]
|
9.83459e-06
|
|
|
LRAT
|
[NCBI]
|
9.83459e-06
|
|
|
LAMP2
|
[NCBI]
|
9.83459e-06
|
|
|
CYP2C9
|
[NCBI]
|
9.83459e-06
|
|
|
RAPSN
|
[NCBI]
|
9.83459e-06
|
|
|
LYST
|
[NCBI]
|
9.83459e-06
|
|
|
LAMA2
|
[NCBI]
|
9.83459e-06
|
|
|
BEST1
|
[NCBI]
|
9.83459e-06
|
|
|
GABRB3
|
[NCBI]
|
9.83459e-06
|
|
|
PRTN3
|
[NCBI]
|
9.83459e-06
|
|
|
KEAP1
|
[NCBI]
|
9.83459e-06
|
|
|
FCGR3A
|
[NCBI]
|
9.83459e-06
|
|
|
AT
|
[NCBI]
|
9.66716e-06
|
|
|
HBB
|
[NCBI]
|
9.57449e-06
|
|
|
HIDS
|
[NCBI]
|
9.56065e-06
|
|
|
CLN2
|
[NCBI]
|
9.56065e-06
|
|
|
HRPT1
|
[NCBI]
|
9.56065e-06
|
|
|
VWM
|
[NCBI]
|
9.56065e-06
|
|
|
BFLS
|
[NCBI]
|
9.56065e-06
|
|
|
pseudohypoparathyroidism, type ib
|
[NCBI]
|
9.56065e-06
|
|
|
ESCS
|
[NCBI]
|
9.56065e-06
|
|
|
NPHP1
|
[NCBI]
|
9.56065e-06
|
|
|
DLG4
|
[NCBI]
|
9.51181e-06
|
|
|
MIF
|
[NCBI]
|
9.51181e-06
|
|
|
CAST
|
[NCBI]
|
9.51181e-06
|
|
|
ROR2
|
[NCBI]
|
9.51181e-06
|
|
|
EXT2
|
[NCBI]
|
9.20852e-06
|
|
|
NEFL
|
[NCBI]
|
9.20852e-06
|
|
|
ADSL
|
[NCBI]
|
9.20852e-06
|
|
|
GJA3
|
[NCBI]
|
9.20852e-06
|
|
|
GLUD1
|
[NCBI]
|
9.20852e-06
|
|
|
LTF
|
[NCBI]
|
9.20852e-06
|
|
|
TSHB
|
[NCBI]
|
9.20852e-06
|
|
|
GNRH1
|
[NCBI]
|
9.10243e-06
|
|
|
ADHD
|
[NCBI]
|
9.00178e-06
|
|
|
SMN1
|
[NCBI]
|
8.98648e-06
|
|
|
COL2A1
|
[NCBI]
|
8.98648e-06
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
8.92264e-06
|
|
|
FGF9
|
[NCBI]
|
8.92264e-06
|
|
|
G6PT1
|
[NCBI]
|
8.92264e-06
|
|
|
RETN
|
[NCBI]
|
8.92264e-06
|
|
|
IL9
|
[NCBI]
|
8.92264e-06
|
|
|
FOXL2
|
[NCBI]
|
8.92264e-06
|
|
|
XRCC9
|
[NCBI]
|
8.92264e-06
|
|
|
FRAXE
|
[NCBI]
|
8.92264e-06
|
|
|
LMX1B
|
[NCBI]
|
8.92264e-06
|
|
|
HADHA
|
[NCBI]
|
8.92264e-06
|
|
|
FGF3
|
[NCBI]
|
8.92264e-06
|
|
|
KCNE1
|
[NCBI]
|
8.92264e-06
|
|
|
PRKCG
|
[NCBI]
|
8.92264e-06
|
|
|
ECM1
|
[NCBI]
|
8.92264e-06
|
|
|
stroke, ischemic
|
[NCBI]
|
8.84333e-06
|
|
|
PARK8
|
[NCBI]
|
8.84333e-06
|
|
|
SST
|
[NCBI]
|
8.80347e-06
|
|
|
GCK
|
[NCBI]
|
8.78805e-06
|
|
|
GAPDH
|
[NCBI]
|
8.77668e-06
|
|
|
WNK1
|
[NCBI]
|
8.65244e-06
|
|
|
C9
|
[NCBI]
|
8.65244e-06
|
|
|
NEB
|
[NCBI]
|
8.65244e-06
|
|
|
DMBT1
|
[NCBI]
|
8.65244e-06
|
|
|
NCSTN
|
[NCBI]
|
8.65244e-06
|
|
|
HSD11B1
|
[NCBI]
|
8.65244e-06
|
|
|
NRL
|
[NCBI]
|
8.39643e-06
|
|
|
CUBN
|
[NCBI]
|
8.39643e-06
|
|
|
SSTR2
|
[NCBI]
|
8.39643e-06
|
|
|
PEX7
|
[NCBI]
|
8.39643e-06
|
|
|
CGL2
|
[NCBI]
|
8.1788e-06
|
|
|
ETM1
|
[NCBI]
|
8.1788e-06
|
|
|
CCAL2
|
[NCBI]
|
8.1788e-06
|
|
|
TRPS1
|
[NCBI]
|
8.1788e-06
|
|
|
HSAN1
|
[NCBI]
|
8.1788e-06
|
|
|
UCMD
|
[NCBI]
|
8.1788e-06
|
|
|
KRT1
|
[NCBI]
|
8.1533e-06
|
|
|
DLK1
|
[NCBI]
|
8.1533e-06
|
|
|
CPM
|
[NCBI]
|
8.1533e-06
|
|
|
SYP
|
[NCBI]
|
8.1533e-06
|
|
|
F12
|
[NCBI]
|
8.1533e-06
|
|
|
CYP27B1
|
[NCBI]
|
8.1533e-06
|
|
|
EBP
|
[NCBI]
|
8.1533e-06
|
|
|
GH1
|
[NCBI]
|
8.13373e-06
|
|
|
HPS
|
[NCBI]
|
8.0772e-06
|
|
|
SRY
|
[NCBI]
|
7.95744e-06
|
|
|
TYR
|
[NCBI]
|
7.95744e-06
|
|
|
AACT
|
[NCBI]
|
7.92195e-06
|
|
|
RHD
|
[NCBI]
|
7.92195e-06
|
|
|
APTX
|
[NCBI]
|
7.92195e-06
|
|
|
CYP1B1
|
[NCBI]
|
7.92195e-06
|
|
|
GNAS
|
[NCBI]
|
7.78554e-06
|
|
|
CDSN
|
[NCBI]
|
7.70138e-06
|
|
|
SLC17A6
|
[NCBI]
|
7.70138e-06
|
|
|
MC1R
|
[NCBI]
|
7.61788e-06
|
|
|
thrombocythemia, essential
|
[NCBI]
|
7.56204e-06
|
|
|
MDC1A
|
[NCBI]
|
7.56204e-06
|
|
|
CHAC
|
[NCBI]
|
7.56204e-06
|
|
|
sialuria, finnish type
|
[NCBI]
|
7.56204e-06
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
7.56204e-06
|
|
|
UOX
|
[NCBI]
|
7.56204e-06
|
|
|
SLC6A3
|
[NCBI]
|
7.53656e-06
|
|
|
FKRP
|
[NCBI]
|
7.49074e-06
|
|
|
MIP
|
[NCBI]
|
7.49074e-06
|
|
|
FMR1
|
[NCBI]
|
7.47616e-06
|
|
|
TTR
|
[NCBI]
|
7.4382e-06
|
|
|
MTM1
|
[NCBI]
|
7.28926e-06
|
|
|
MAOA
|
[NCBI]
|
7.13882e-06
|
|
|
SLC22A5
|
[NCBI]
|
7.09626e-06
|
|
|
CRYAB
|
[NCBI]
|
7.09626e-06
|
|
|
CTSK
|
[NCBI]
|
7.09626e-06
|
|
|
OPA1
|
[NCBI]
|
7.09626e-06
|
|
|
PPID
|
[NCBI]
|
7.09626e-06
|
|
|
hodgkin lymphoma
|
[NCBI]
|
6.98869e-06
|
|
|
MADA
|
[NCBI]
|
6.98869e-06
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
6.98869e-06
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
6.94637e-06
|
|
|
CHRNE
|
[NCBI]
|
6.91113e-06
|
|
|
PRKAR1A
|
[NCBI]
|
6.91113e-06
|
|
|
MYCN
|
[NCBI]
|
6.91113e-06
|
|
|
DYT1
|
[NCBI]
|
6.91113e-06
|
|
|
PROP1
|
[NCBI]
|
6.91113e-06
|
|
|
ABCC8
|
[NCBI]
|
6.838e-06
|
|
|
BRCA1
|
[NCBI]
|
6.76545e-06
|
|
|
PITX2
|
[NCBI]
|
6.73334e-06
|
|
|
NOG
|
[NCBI]
|
6.73334e-06
|
|
|
FABP2
|
[NCBI]
|
6.73334e-06
|
|
|
TIMP1
|
[NCBI]
|
6.73334e-06
|
|
|
COL17A1
|
[NCBI]
|
6.73334e-06
|
|
|
TFF1
|
[NCBI]
|
6.73334e-06
|
|
|
IGF2R
|
[NCBI]
|
6.73334e-06
|
|
|
ESR1
|
[NCBI]
|
6.69278e-06
|
|
|
LAM
|
[NCBI]
|
6.64977e-06
|
|
|
LPI
|
[NCBI]
|
6.57504e-06
|
|
|
RB1
|
[NCBI]
|
6.57432e-06
|
|
|
RYR2
|
[NCBI]
|
6.56238e-06
|
|
|
ETV6
|
[NCBI]
|
6.56238e-06
|
|
|
TP73L
|
[NCBI]
|
6.56238e-06
|
|
|
TG
|
[NCBI]
|
6.56103e-06
|
|
|
ATM
|
[NCBI]
|
6.55086e-06
|
|
|
XDH
|
[NCBI]
|
6.52679e-06
|
|
|
CRMO
|
[NCBI]
|
6.45498e-06
|
|
|
RMD
|
[NCBI]
|
6.45498e-06
|
|
|
alcohol dependence
|
[NCBI]
|
6.45498e-06
|
|
|
glycogen storage disease ib
|
[NCBI]
|
6.45498e-06
|
|
|
ACVRL1
|
[NCBI]
|
6.39783e-06
|
|
|
IL1B
|
[NCBI]
|
6.39783e-06
|
|
|
ATXN1
|
[NCBI]
|
6.39783e-06
|
|
|
DPYD
|
[NCBI]
|
6.39783e-06
|
|
|
CAV3
|
[NCBI]
|
6.39783e-06
|
|
|
FTL
|
[NCBI]
|
6.23928e-06
|
|
|
ALDH3A2
|
[NCBI]
|
6.23928e-06
|
|
|
COL6A1
|
[NCBI]
|
6.23928e-06
|
|
|
CRY1
|
[NCBI]
|
6.23928e-06
|
|
|
GCH1
|
[NCBI]
|
6.23928e-06
|
|
|
SLC40A1
|
[NCBI]
|
6.23928e-06
|
|
|
ENPP1
|
[NCBI]
|
6.08636e-06
|
|
|
KRT5
|
[NCBI]
|
6.08636e-06
|
|
|
MAOB
|
[NCBI]
|
6.08636e-06
|
|
|
IL8
|
[NCBI]
|
6.08636e-06
|
|
|
DYSF
|
[NCBI]
|
6.08636e-06
|
|
|
RECQL3
|
[NCBI]
|
6.08636e-06
|
|
|
MRXHF1
|
[NCBI]
|
5.95761e-06
|
|
|
PNKD1
|
[NCBI]
|
5.95761e-06
|
|
|
IL5
|
[NCBI]
|
5.93875e-06
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
5.79615e-06
|
|
|
RARA
|
[NCBI]
|
5.79615e-06
|
|
|
SPG4
|
[NCBI]
|
5.79615e-06
|
|
|
TYMS
|
[NCBI]
|
5.66913e-06
|
|
|
GDF5
|
[NCBI]
|
5.65826e-06
|
|
|
ICAM1
|
[NCBI]
|
5.65826e-06
|
|
|
GHRL
|
[NCBI]
|
5.65826e-06
|
|
|
TACR1
|
[NCBI]
|
5.65826e-06
|
|
|
BRCA2
|
[NCBI]
|
5.6416e-06
|
|
|
ABCC6
|
[NCBI]
|
5.52485e-06
|
|
|
PTHR1
|
[NCBI]
|
5.52485e-06
|
|
|
PRPH2
|
[NCBI]
|
5.52485e-06
|
|
|
ADA
|
[NCBI]
|
5.51187e-06
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
5.49365e-06
|
|
|
ESR2
|
[NCBI]
|
5.39566e-06
|
|
|
ADRP
|
[NCBI]
|
5.39566e-06
|
|
|
LTA
|
[NCBI]
|
5.39566e-06
|
|
|
BAX
|
[NCBI]
|
5.39566e-06
|
|
|
BGN
|
[NCBI]
|
5.39566e-06
|
|
|
CPI
|
[NCBI]
|
5.37583e-06
|
|
|
FANCC
|
[NCBI]
|
5.2705e-06
|
|
|
PTPRC
|
[NCBI]
|
5.2705e-06
|
|
|
CHEK2
|
[NCBI]
|
5.2705e-06
|
|
|
ADRB2
|
[NCBI]
|
5.2705e-06
|
|
|
PGR
|
[NCBI]
|
5.21183e-06
|
|
|
EDNRB
|
[NCBI]
|
5.14914e-06
|
|
|
CBX5
|
[NCBI]
|
5.12559e-06
|
|
|
OKS
|
[NCBI]
|
5.06055e-06
|
|
|
DFNB1
|
[NCBI]
|
5.06055e-06
|
|
|
MYH11
|
[NCBI]
|
5.03142e-06
|
|
|
LIFR
|
[NCBI]
|
4.91715e-06
|
|
|
TNF
|
[NCBI]
|
4.8958e-06
|
|
|
CTLA4
|
[NCBI]
|
4.80618e-06
|
|
|
FOLH1
|
[NCBI]
|
4.80618e-06
|
|
|
SOCS1
|
[NCBI]
|
4.69836e-06
|
|
|
usher syndrome, type i
|
[NCBI]
|
4.65602e-06
|
|
|
neural tube defects
|
[NCBI]
|
4.65602e-06
|
|
|
SPDA1
|
[NCBI]
|
4.65602e-06
|
|
|
BOR1
|
[NCBI]
|
4.65602e-06
|
|
|
POF1
|
[NCBI]
|
4.65602e-06
|
|
|
POLG
|
[NCBI]
|
4.59354e-06
|
|
|
CYP17A1
|
[NCBI]
|
4.59354e-06
|
|
|
RUNX1
|
[NCBI]
|
4.49159e-06
|
|
|
TCRA
|
[NCBI]
|
4.49159e-06
|
|
|
ZNF145
|
[NCBI]
|
4.49159e-06
|
|
|
SCA2
|
[NCBI]
|
4.48512e-06
|
|
|
ATRX
|
[NCBI]
|
4.3924e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
4.3924e-06
|
|
|
VLDLR
|
[NCBI]
|
4.3924e-06
|
|
|
DCT
|
[NCBI]
|
4.29584e-06
|
|
|
TSC1
|
[NCBI]
|
4.29584e-06
|
|
|
leiomyomatosis and renal cell cancer, hereditary
|
[NCBI]
|
4.278e-06
|
|
|
SPP1
|
[NCBI]
|
4.18252e-06
|
|
|
NTRK1
|
[NCBI]
|
4.11022e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
4.05134e-06
|
|
|
MTAP
|
[NCBI]
|
4.02096e-06
|
|
|
DSG3
|
[NCBI]
|
3.93394e-06
|
|
|
DKC
|
[NCBI]
|
3.92468e-06
|
|
|
MCOPS7
|
[NCBI]
|
3.92468e-06
|
|
|
FRDA
|
[NCBI]
|
3.92247e-06
|
|
|
FH
|
[NCBI]
|
3.84908e-06
|
|
|
LPL
|
[NCBI]
|
3.78582e-06
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
3.77709e-06
|
|
|
B2M
|
[NCBI]
|
3.7663e-06
|
|
|
FXN
|
[NCBI]
|
3.7663e-06
|
|
|
EKD1
|
[NCBI]
|
3.72899e-06
|
|
|
OTC
|
[NCBI]
|
3.60668e-06
|
|
|
KIT
|
[NCBI]
|
3.60668e-06
|
|
|
IL2
|
[NCBI]
|
3.59535e-06
|
|
|
BCPM
|
[NCBI]
|
3.59441e-06
|
|
|
LGMD2C
|
[NCBI]
|
3.59441e-06
|
|
|
FPLD2
|
[NCBI]
|
3.59441e-06
|
|
|
exostoses, multiple, type i
|
[NCBI]
|
3.59441e-06
|
|
|
DNMT1
|
[NCBI]
|
3.55024e-06
|
|
|
LBR
|
[NCBI]
|
3.5297e-06
|
|
|
ALB
|
[NCBI]
|
3.51245e-06
|
|
|
PSEN2
|
[NCBI]
|
3.45452e-06
|
|
|
diaphragmatic hernia, congenital
|
[NCBI]
|
3.44549e-06
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
3.28569e-06
|
|
|
DJS
|
[NCBI]
|
3.28569e-06
|
|
|
FCHL
|
[NCBI]
|
3.28569e-06
|
|
|
cystinuria
|
[NCBI]
|
3.28569e-06
|
|
|
CDH1
|
[NCBI]
|
3.23918e-06
|
|
|
PGK1
|
[NCBI]
|
3.23918e-06
|
|
|
IGF1
|
[NCBI]
|
3.23918e-06
|
|
|
MMP9
|
[NCBI]
|
3.23918e-06
|
|
|
temporal arteritis
|
[NCBI]
|
3.23417e-06
|
|
|
KRAS
|
[NCBI]
|
3.17062e-06
|
|
|
NOS3
|
[NCBI]
|
3.17062e-06
|
|
|
GJB2
|
[NCBI]
|
3.10683e-06
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
3.10358e-06
|
|
|
RTT
|
[NCBI]
|
3.03458e-06
|
|
|
CFTR
|
[NCBI]
|
3.00396e-06
|
|
|
UGT1A1
|
[NCBI]
|
2.97389e-06
|
|
|
WRN
|
[NCBI]
|
2.90757e-06
|
|
|
PEDF
|
[NCBI]
|
2.87029e-06
|
|
|
TGFB1
|
[NCBI]
|
2.84975e-06
|
|
|
CD36
|
[NCBI]
|
2.84975e-06
|
|
|
VDR
|
[NCBI]
|
2.82751e-06
|
|
|
GPT
|
[NCBI]
|
2.78965e-06
|
|
|
CTNNB1
|
[NCBI]
|
2.73083e-06
|
|
|
EVA
|
[NCBI]
|
2.72767e-06
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
2.72767e-06
|
|
|
AQP2
|
[NCBI]
|
2.61684e-06
|
|
|
ABCD1
|
[NCBI]
|
2.61684e-06
|
|
|
FGF7
|
[NCBI]
|
2.54474e-06
|
|
|
F2R
|
[NCBI]
|
2.50751e-06
|
|
|
CADASIL
|
[NCBI]
|
2.47602e-06
|
|
|
CLL
|
[NCBI]
|
2.47602e-06
|
|
|
LOX
|
[NCBI]
|
2.45452e-06
|
|
|
VCP
|
[NCBI]
|
2.45452e-06
|
|
|
LRRK2
|
[NCBI]
|
2.40259e-06
|
|
|
SLC4A1
|
[NCBI]
|
2.40259e-06
|
|
|
PRNP
|
[NCBI]
|
2.38393e-06
|
|
|
FGA
|
[NCBI]
|
2.35171e-06
|
|
|
PAX6
|
[NCBI]
|
2.35171e-06
|
|
|
CDLS1
|
[NCBI]
|
2.31035e-06
|
|
|
PARP1
|
[NCBI]
|
2.25297e-06
|
|
|
RYR1
|
[NCBI]
|
2.25297e-06
|
|
|
malaria, susceptibility to
|
[NCBI]
|
2.24121e-06
|
|
|
kartagener syndrome
|
[NCBI]
|
2.24121e-06
|
|
|
GCPS
|
[NCBI]
|
2.24121e-06
|
|
|
MEB
|
[NCBI]
|
2.24121e-06
|
|
|
BMP2
|
[NCBI]
|
2.20506e-06
|
|
|
UGB
|
[NCBI]
|
2.20506e-06
|
|
|
TSHR
|
[NCBI]
|
2.1581e-06
|
|
|
JAK2
|
[NCBI]
|
2.14029e-06
|
|
|
HRG
|
[NCBI]
|
2.0669e-06
|
|
|
BSG
|
[NCBI]
|
2.02262e-06
|
|
|
LFS1
|
[NCBI]
|
2.02232e-06
|
|
|
lactase persistence
|
[NCBI]
|
2.02232e-06
|
|
|
ASS
|
[NCBI]
|
1.89483e-06
|
|
|
IGAD1
|
[NCBI]
|
1.88598e-06
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
1.8595e-06
|
|
|
VHL
|
[NCBI]
|
1.85385e-06
|
|
|
APS1
|
[NCBI]
|
1.84418e-06
|
|
|
HYPP
|
[NCBI]
|
1.81848e-06
|
|
|
LCT
|
[NCBI]
|
1.81364e-06
|
|
|
UCP3
|
[NCBI]
|
1.7742e-06
|
|
|
HLA-A
|
[NCBI]
|
1.69752e-06
|
|
|
HHF1
|
[NCBI]
|
1.6289e-06
|
|
|
melanoma, uveal
|
[NCBI]
|
1.6289e-06
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
1.62626e-06
|
|
|
HNF1A
|
[NCBI]
|
1.5878e-06
|
|
|
MPZ
|
[NCBI]
|
1.55258e-06
|
|
|
FGF1
|
[NCBI]
|
1.51801e-06
|
|
|
APRT
|
[NCBI]
|
1.49998e-06
|
|
|
SMEI
|
[NCBI]
|
1.45285e-06
|
|
|
TS
|
[NCBI]
|
1.38378e-06
|
|
|
AIRE
|
[NCBI]
|
1.3545e-06
|
|
|
WT1
|
[NCBI]
|
1.29284e-06
|
|
|
KRT20
|
[NCBI]
|
1.26342e-06
|
|
|
IDE
|
[NCBI]
|
1.26342e-06
|
|
|
GTS
|
[NCBI]
|
1.14882e-06
|
|
|
HSAN3
|
[NCBI]
|
1.13868e-06
|
|
|
MODY
|
[NCBI]
|
1.12204e-06
|
|
|
APOB
|
[NCBI]
|
1.06913e-06
|
|
|
DRPLA
|
[NCBI]
|
1.05989e-06
|
|
|
APOE
|
[NCBI]
|
1.04995e-06
|
|
|
wilson disease
|
[NCBI]
|
1.03896e-06
|
|
|
VMD
|
[NCBI]
|
9.99343e-07
|
|
|
LI1
|
[NCBI]
|
9.99343e-07
|
|
|
TP53
|
[NCBI]
|
9.78565e-07
|
|
|
EDMD
|
[NCBI]
|
8.71111e-07
|
|
|
BLM
|
[NCBI]
|
8.67205e-07
|
|
|
LS
|
[NCBI]
|
8.67205e-07
|
|
|
DBA
|
[NCBI]
|
8.37953e-07
|
|
|
giant platelet syndrome
|
[NCBI]
|
8.37953e-07
|
|
|
CFH
|
[NCBI]
|
8.11233e-07
|
|
|
GJA1
|
[NCBI]
|
7.98455e-07
|
|
|
UCP2
|
[NCBI]
|
7.90272e-07
|
|
|
TPMT
|
[NCBI]
|
7.90272e-07
|
|
|
GJB1
|
[NCBI]
|
7.90272e-07
|
|
|
small cell cancer of the lung
|
[NCBI]
|
7.31018e-07
|
|
|
MCDR1
|
[NCBI]
|
7.31018e-07
|
|
|
TH
|
[NCBI]
|
7.23674e-07
|
|
|
FMF
|
[NCBI]
|
6.87461e-07
|
|
|
OPMD
|
[NCBI]
|
6.87137e-07
|
|
|
von willebrand disease
|
[NCBI]
|
6.72483e-07
|
|
|
MITF
|
[NCBI]
|
6.72483e-07
|
|
|
LWD
|
[NCBI]
|
6.45967e-07
|
|
|
cayler cardiofacial syndrome
|
[NCBI]
|
6.13388e-07
|
|
|
PXE
|
[NCBI]
|
5.83137e-07
|
|
|
STAR
|
[NCBI]
|
5.81743e-07
|
|
|
SMA1
|
[NCBI]
|
5.63459e-07
|
|
|
neuroblastoma
|
[NCBI]
|
5.48143e-07
|
|
|
CP
|
[NCBI]
|
5.45131e-07
|
|
|
INSR
|
[NCBI]
|
5.3513e-07
|
|
|
DDC
|
[NCBI]
|
5.19428e-07
|
|
|
CCD
|
[NCBI]
|
4.96326e-07
|
|
|
KDR
|
[NCBI]
|
4.8895e-07
|
|
|
SMAX1
|
[NCBI]
|
4.83881e-07
|
|
|
LNS
|
[NCBI]
|
4.59593e-07
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
4.50471e-07
|
|
|
TBP
|
[NCBI]
|
4.45484e-07
|
|
|
breast cancer
|
[NCBI]
|
4.32908e-07
|
|
|
LRP1
|
[NCBI]
|
4.26292e-07
|
|
|
UCP1
|
[NCBI]
|
4.0462e-07
|
|
|
BWS
|
[NCBI]
|
3.80254e-07
|
|
|
HHT
|
[NCBI]
|
3.7993e-07
|
|
|
HNPP
|
[NCBI]
|
3.7993e-07
|
|
|
GC
|
[NCBI]
|
3.54e-07
|
|
|
TF
|
[NCBI]
|
3.46241e-07
|
|
|
TLR4
|
[NCBI]
|
3.39947e-07
|
|
|
MHS1
|
[NCBI]
|
3.08791e-07
|
|
|
FGF2
|
[NCBI]
|
2.85889e-07
|
|
|
PSACH
|
[NCBI]
|
2.65988e-07
|
|
|
IL6
|
[NCBI]
|
2.55158e-07
|
|
|
POMC
|
[NCBI]
|
2.5256e-07
|
|
|
CASR
|
[NCBI]
|
2.26533e-07
|
|
|
DHFR
|
[NCBI]
|
2.05103e-07
|
|
|
MFS
|
[NCBI]
|
1.97341e-07
|
|
|
TPO
|
[NCBI]
|
1.90101e-07
|
|
|
GHR
|
[NCBI]
|
1.84124e-07
|
|
|
ALS1
|
[NCBI]
|
1.75288e-07
|
|
|
RCC1
|
[NCBI]
|
1.43215e-07
|
|
|
FGFR3
|
[NCBI]
|
1.24869e-07
|
|
|
EV
|
[NCBI]
|
1.11355e-07
|
|
|
SERPINA6
|
[NCBI]
|
1.10462e-07
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
1.08124e-07
|
|
|
CMT1A
|
[NCBI]
|
1.02204e-07
|
|
|
APP
|
[NCBI]
|
1.00613e-07
|
|
|
NPC1
|
[NCBI]
|
6.97106e-08
|
|
|
SLS
|
[NCBI]
|
6.97106e-08
|
|
|
IHH
|
[NCBI]
|
5.22226e-08
|
|
|
SHBG
|
[NCBI]
|
4.94752e-08
|
|
|
HFE
|
[NCBI]
|
4.83255e-08
|
|
|
ATD1
|
[NCBI]
|
4.69085e-08
|
|
|
BPES
|
[NCBI]
|
4.32131e-08
|
|
|
DGS
|
[NCBI]
|
2.8611e-08
|
|
|
MEN2A
|
[NCBI]
|
2.80244e-08
|
|
|
MKS1
|
[NCBI]
|
2.32262e-08
|
|
|
phenylketonuria
|
[NCBI]
|
9.54237e-09
|
|
|
HD
|
[NCBI]
|
3.87364e-09
|
|
|
KCNH2
|
[NCBI]
|
2.63295e-09
|
|
|
FTD
|
[NCBI]
|
8.35227e-10
|
|
|
CES
|
[NCBI]
|
1.03795e-10
|
|